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Summary 
 
Modern toxicology puts together existing knowledge of classical 
biology with new technologies to study effects of perturbations and 
to predict adverse outcomes resulting from those perturbations. 
Modern toxicology employs high throughput technology as 
microarray and cell lines as in vitro models to investigate the effect 
of potential toxic compounds. 
In my thesis I evaluate the usefulness and reproducibility of 
microarray technology and cell line models. I have been mainly 
interested in the study of the effects on the regulation of gene 
transcription in cell lines. I used HepG2 cell line as a model for 
liver to study cadmium-induced cytotoxicity, Caco-2 as model for 
intestinal epithelial to study nanoparticles and HeLa cells from 
cervical cancer to evaluate genomic instability. 
Cadmium is currently classified as carcinogen for human. In my 
first study, gene expression is used to explain the possible toxic 
mechanism of cadmium carcinogenity, using HepG2 cell line. A 
suggested mechanism of cadmium-induced carcinogenicity 
involves defects in the cell response to DNA damage and in the 
resistance to apoptosis. In this regard, I focused on the tumour 
suppressor protein P53, since its inactivation is a common feature 
found in human cancers and it is a crucial component of the cellular 
response to DNA damage. The results presented in this thesis 
demonstrate that in HepG2 cells exposed to cadmium, P53 was 
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correctly moved and accumulated into the nucleus to accomplish its 
function as a transcription factor. However, in spite of this correct 
nuclear localization, the signals for the cell cycle arrest were not 
activated. In this context, the important mediator of cell cycle arrest 
P21, a P53 downstream protein, was upregulated at the gene level 
but not at the protein level. These results could be explained by the 
involvement of a post-transcriptional activity mediated by miRNA, 
as demonstrated by the upregulation of mir-372 in cadmium-treated 
HepG2 cells, which was able to affect p21 expression and to 
promote cell proliferation. 
Recent advances in materials science have resulted in the creation 
of particles in the nano-scale range and their use is spreading. This 
creates the need to evaluate their possible toxic effect on human 
health. In the second study, gene expression is applied to evaluate 
nanoparticle effect on Caco-2 cells as in vitro model of intestinal 
epithelial cells. The main focus was to compare the effect of gold 
nanoparticles (AuNP) of two sizes (30 nm and 5 nm), using 
microarray technology. Smaller AuNPs (5 nm) inhibit Caco-2 cell 
growth. Gene expression analysis shows a broad range of responses 
induced by small size AuNPs. A bioinformatics reconstruction of 
the possible pathways regulated by smaller AuNPs indicates that 
Caco-2 cells activate defence responses even if it was not enough 
to prevent the observed toxic effect. The response at the 
transcriptome level upon exposure to larger AuNPs (30 nm) is very 
weak. This effect can be due to the low uptake of these larger 
AuNPs. 
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The third study focuses on the issue concerning cell line variability 
using different batches of HeLa cells obtained from different 
laboratories. The microarray expression analysis was performed on 
different batches of HeLa cells exposed to hypoxic conditions. In 
response to a hypoxic stimulus, each cell line batch activated 
different pathways, although the regulation of genes related to 
hypoxia is conserved. A genetic analysis show the high level of 
extensive chromosome instability in HeLa clones obtained from 
different laboratories. Each clone accumulates genomic variability 
in a time-dependent manner. The large differences in gene 
expression profiles suggest that the use of uncharacterized clones 
may lead to faulty conclusions and to irreproducible results in 
studies of gene function and pathway analysis.  
In the three papers presented in this thesis I have not only shown 
the reproducibility of microarray by comparison to real time PCR, 
the gold standard technique for mRNA quantification, but also the 
potential to create possible model for the mechanistic effects on 
biological pathways. 
In my thesis I have used different cell lines as in vitro models. They 
have shown that they have many advantages and that can give 
strong support for modern toxicology and be used to study 
biological mechanism. However, a possible drawback, which 
should be taken into account, is highlighted in the third study 
showing a high variability in the responses of different batches of 
the same cell line. 
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Aim of the thesis 
 
The focus of my PhD study was the application of high throughput 
technology to investigate cellular models which may be highly 
informative for the study of human pathological conditions and of 
the effects of toxic compounds. I have been mainly interested in the 
study of the effects of different compounds on the regulation of 
gene transcription and in the evaluation of cell lines as in vitro 
models. To this end I used Caco-2 as model of intestinal epithelial 
cell to study cadmium, HepG2 as a model of hepatic cell, to study 
nanoparticles and HeLa cells from cervical cancer to evaluate 
genomic instability after having been cultured in different 
laboratories for several years. 
I mainly studied the transcriptional responses that I evaluated by a 
high throughput technology such as microarray. This technology 
allows evaluating the expression of the entire genome in a single 
experiment. Furthermore, I investigated microRNAs, small RNAs 
that regulate the expression of thousands of genes at post-
transcriptional, both in normal physiologic and pathological 
conditions. 
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Modern toxicology 
 
Recent improvements in biological understanding and technologies 
(high throughput), have allowed the contemplation of a new 
approach to understand disease and toxicology. This modern 
approach puts together existing knowledge of classical biology 
with new chemical and biological information about the effect of 
perturbations, leading to a hypothesis-based approach to predict 
adverse outcomes resulting from those perturbations. This general 
approach has been termed Adverse Outcome Pathway (AOP), as 
described by Ankely and colleagues [1]. An AOP describes the 
events that occur after a chemical exposure, starting from the 
interaction of the chemical with a biomolecule (e.g., protein, 
receptor) that it is called the Molecular Initiating Event (MIE), 
followed by a description of the cellular and tissue perturbations 
that can produce a toxicological effect also called adverse outcome. 
The cells respond to the change in their environment to maintain 
physiological condition but when they are not still able to maintain 
physiological condition, different processes are induced. In 
assessing cellular stress, Warringer and colleagues [2] suggested 
three phases of response: the most immediate response occurs via 
protein stabilization and modification, followed by translational 
reprogramming and finally by a slower, and more energy costing 
transcriptional response. 
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Toxicogenomics 
 
The history of molecular biology starts with the discovery of DNA 
structure by Watson and Crick (1953), 20 years later, Southern blot 
and Northern blot allowed to “visualize” the presence of genetic 
material. Nowadays, Southern and Northern blots are not 
frequently used. These methods are now replaced with more rapid 
and higher throughput methods that need very small amounts of 
sample material and enable analyses of molecular events at a 
whole-genomic level.  
The most enabling technology for such approaches is the 
microarray chip, first published in the mid-1990’s [3]. The result 
was a miniature array that could allow the probing of the whole-
genomic transcript profile.  
The application of array technology in toxicology experiments 
provided the basis for the emergence of a new field, the 
toxicogenomics. Today, the term toxicogenomics represents the 
interface of multiple functional genomics approaches applied to 
understand mechanisms of toxicity. 
The possibility to characterize the population of transcribed genes 
led to the creation of a new term, the transcriptome [4]. This 
concept defines the complete set of transcribed genes expressed as 
messenger RNAs for a particular species. The transcriptome, 
therefore, represents the universe of RNA messengers that may 
code for proteins. Only approximately 5% of genes are active in a 
particular cell at any given point in time. Most of the genes are 
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repressed, and this control may occur at either the transcriptional or 
the translational level. Since the regulation of protein expression at 
the level of transcription is more efficient, control mainly takes 
place at this level. The gene expression profile of a cell determines 
its function, phenotype and response to external stimuli. Therefore, 
gene expression profiles can help to elucidate cellular functions, 
biochemical pathways and regulatory mechanisms. In addition, 
gene expression profiles of disease cells or tissues, compared with 
normal controls, may promote the understanding of disease 
pathology and identify new therapeutic options, improving 
diagnosis and clarifying prognosis. 
 
MicroRNA 
 
MicroRNA (miRNA), a biologically relevant group of RNA 
molecules is gaining interest. Involvement of miRNAs for gene 
regulation and their biogenesis have been described in few review 
articles [5]–[7]. In silico prediction estimates that ∼60% of human 
mRNAs could be targets of miRNAs [8]. Similar to mRNA, 
miRNAs are expressed in a tissue- or cell-specific manner. 
MiRNAs can potentially regulate every aspect of cellular processes 
such as differentiation, proliferation, apoptosis, and necrosis as 
well as a large range of physiological processes [9].  
The miRNA regulatory networks are complex because a single 
miRNA can target numerous mRNAs, often in combination with 
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other miRNAs; thus, an understanding of miRNA roles in 
toxicological processes requires an overall toxicogenomics 
approach. Studies that employ toxicogenomics have been 
performed, e.g., to evaluate the miRNA responses in rodent livers 
in order to identify potential biomarkers for toxicological risk 
assessment [10]. 
 
High throughput technologies 
 
Microarray 
Microarray is a high throughput technology for detection and 
characterization of DNA and RNA. This whole genome technology 
can be applied for different analysis, transcription analysis, 
detection and characterization of genetic variants [11] and 
toxicology [12]. The microarray is a collection of microscopic 
DNA spots attached to a solid surface [11]. Each spot contains a 
few picomole amount of a specific probe. Probes can be a short 
sequence of a gene or a DNA element used for hybridization of 
RNA or DNA in the sample (target) under stringent conditions. The 
probes are produced and attached to a solid surface by a covalent 
binding to a chemical matrix in commercial microarrays. 
According to different manufacturers the solid surface can be a 
glass or a silicon chip, alternatively, microarrays can be constructed 
by the direct synthesis of oligonucleotide probes on solid surfaces. 
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Microarrays allow measure global changes in gene expression 
(Fig.1). The signal is detected, quantified, integrated and 
normalized with software and reflect the gene expression profile or 
molecular portrait of a given biological sample. However, this 
molecular analysis depends on the number and type of probes 
spotted on a slide, thus in microarrays, only molecules that are 
searched, can be found. 
Numerous commercial microarray platforms covering human or 
model animal genomes are commercially available. 
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Fig 1. Schematic representation of a typical gene expression study. 
The mRNA of two samples is isolated and labelled. The labelled RNA is 
hybridized on the slide. In the last step the signal is detected, quantified, 
integrated and normalized. 
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Microfluidic cards 
Microfluidic Cards are high throughput tools for quantitative 
analysis of mRNA or miRNA transcripts using a real-time PCR 
protocol. This technology utilizes a microfluidic card with 384 
reaction chambers and eight sample loading ports. In the studies of 
coding transcripts, the reaction chambers are preloaded with user 
selected or predefined panels of TaqMan Gene Expression Assays 
[13]. These assays enable real-time monitoring of a PCR reaction 
via hydrolysis of an oligonucleotide probe which has been dual 
labelled with fluorescent dye and quencher. Applications of 
TaqMan Array Cards include verification of microarray results, as 
well as hypothesis driven testing of panels of genes selected for 
their biological functions and relationships.  
 
Bioinformatics analysis 
 
The spread of toxicogenomics to the forefront as an area of 
research investigation [14], followed the initial success of large-
scale genome projects to areas such as cancer, immunology and 
development. The first toxicogenomics experiments follow 
transcript changes after exposure of cells or tissues to a compound. 
The validation of the hypothesis that these changes lead to a 
possibility to group compounds with similar effects and to propose 
mechanistic insights previously unknown with the chemical action. 
This approach requires technical precision of processing 
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components of the experiments, and complex computational and 
bioinformatics approaches. With the abundance of the genomic 
data collected from series of microarray experiments, scientists 
realized that databases and analytical tools were essential in order 
to effectively manage and present the data into a new approach 
[15]. Scientists with different backgrounds began to develop 
analytical tools and to share resources for microarray gene 
expression data.  
 
Gene expression analysis 
Analysis of gene expression data can follow different approaches 
including class discovery, comparison, prediction, and pathway 
analysis. 
One the most successful and used analytical tools developed for 
microarray are the clustering algorithm. The Eisen laboratory [16] 
implemented the use of the hierarchical clustering methodology 
(creating groups of genes and samples based on similarity of 
expression measurements) to analyse cell cycle time course [17] 
and displayed the relationship of the genes according to their 
distance relative to one another on a dendrogram expression 
illustrated by a colour gradient heat map. The result of the 
clustering of gene expression data is an assessment of the co-
expression of genes within or between samples and the presumed 
coregulation of genes based on regulatory processes. Waring and 
colleagues [18] were one of the first groups to use clustering to 
analyse toxicogenomics data. Strong correlation between the 
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histopathology, clinical chemistry, and gene expression profiles 
from rats treated with different known hepatotoxicants was 
revealed, and genes were identified with expression level that 
correlated strongly with effects on clinical chemistry parameters. 
At the very least, investigators in the field of toxicogenomics are 
often interested in a basic question of whether or not there are a set 
of gene expression profiles that can separate two or more classes of 
samples according to a particular exposure condition or phenotype. 
There are some regulatory pathways catalogued in biological 
resources [19], most of these regulatory networks are constructed 
from gene interactions evaluated under normal conditions and that 
can be regulated in responses to environmental factors, toxicants, 
and other forms of stressors.  
The study of biological pathways is a key to understand the 
different processes inside a cell: proteins exert their function not in 
isolation but in a tightly controlled network of interactions and 
reactions. Activation of a pathway typically leads to a change of 
state in the cell: as examples, a set of genes is transcribed, new 
molecules are assembled, molecules are secreted, or new signals 
are recognized. Pathways come in different flavours, depending on 
their functions in the cell, the three main types being metabolic 
pathways, gene regulatory pathways and signalling pathways. 
Biological pathways are generally derived from experimental work 
in cell culture or model organisms. Many different studies are 
collected and integrated over time by initiatives like KEGG [19], 
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Reactome [20], BioCyc [21], or the user-curated WikiPathways 
[22]. 
 
Prediction of microRNA targets 
MicroRNAs (miRNAs) play an important role in 
posttranscriptional regulation of target genes both in plant and 
animal cells. It is estimated that more than half of mammalian 
coding-genes are regulated by miRNAs and most human mRNAs 
are potential target of miRNAs [8], [23]. MiRNAs downregulate 
gene expression mostly by imperfect binding to complementary 
sites within transcript sequences. This imperfect binding suppresses 
their translation, stimulate their deadenylation and degradation or 
induce their cleavage [5], [24]. MiRNAs have been shown to be 
crucial for the majority of physiological processes. Therefore, their 
deregulation has been associated with many diseases such as 
cancer, cardiovascular and neurodegenerative diseases or metabolic 
disorders [25]. Hence, miRNA expression analysis has a diagnostic 
value, and the comparison with healthy miRNA levels is one of the 
promising therapeutic approaches [26]. Effective prediction of 
miRNA-mRNA interactions in animal systems remains challenging 
due to the interaction complexity, and a limited knowledge of rules 
governing these processes. Therefore, it is necessary to take 
advantage of the newest findings in miRNA biology and their 
targets prediction algorithms to find possible miRNA-mRNA 
interactions.  
 
  
19 
 
Cell lines as in vitro models 
 
The use of toxicogenomics was applied to the study of in vitro 
experiments, and several studies have shown the validity of 
toxicogenomics-based in vitro systems for toxicity evaluation. One 
of the first studies [18] was promising, followed by a report on the 
use of primary cultured rat hepatocytes to identify two 
toxicological classes [27]. However, it is known that in vitro 
systems are different from in vivo studies, mainly in metabolic 
functions that are important for drug toxicity. By comparing 
various animal-free liver models against liver tissue in terms of 
their gene expression profiles, Boess and colleagues [28] 
demonstrated that the gene expression of primary hepatocyte 
cultures has moderate similarity to the liver, whereas two selected 
cell lines are quite different from whole liver. The authors 
suggested that although in vitro experiments are an indispensable 
research tool, the limitations of the experimental design of cell 
culture studies should be kept in mind [29]. 
Cell culture technologies form the basis of most alternative 
methods in toxicology. They are a mature technology, but still 
some limitations remain. It is important to be aware of limitations 
that impact on the predictive value of test systems based on cell 
cultures [30]. The main question is, how well the cell in culture 
reproduces the cell in the organism, in particular about its state of 
differentiation and its response patterns in an artificial 
environment. Differentiation can be seen as the cellular equivalent 
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of the phenotype at the level of an organism: which genes are 
expressed at a given time point and which functionality do they 
allow? This critical appraisal of the problems of current cell culture 
techniques does not mean that in vitro systems are not useful, but 
stresses the need to critically evaluate the predictive value of these 
models in each and every case. This emphasizes the need for 
validation, either in a formal sense for standardised tests or as a 
quality assurance process for the in vitro models in research and 
cell based screening approaches. Furthermore, cell lines can change 
with time. 
 
HepG2 
HepG2 cell line was isolated from a human hepatocellular 
carcinoma and it is one of the most used human hepatic cell model 
[31]. Although some studies attribute sufficient metabolic activities 
to these cells [32], they are in general considered to lack substantial 
liver-specific functions and hepatic enzyme activity [33]. The 
human origin of this hepatic cell line and its high rate of cellular 
proliferation, which represents a sensitive end-point for 
cytotoxicity potential, still make the HepG2 cells a relevant cell 
line in basal toxicity testing. 
The main advantage of HepG2 cells is that they have retained the 
activities of several phase I and phase II xenobiotic metabolising 
enzymes [34]. The HepG2 cells are able to form structures typical 
of normal hepatocytes, express liver-specific functions, are metal 
responsive, and, more in general, are well characterized, thus 
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making them a useful model for mechanistic studies on cadmium 
carcinogenicity [35], [36]. 
 
Caco-2 
Caco-2 cell line was initially used as an in vitro model system for 
studying human intestinal permeability for its characteristics shared 
with the small intestinal epithelium as to cell morphology, polarity, 
and enterocytic differentiation [37]. Its suitability for intestinal 
permeability screening was initially confirmed when strong 
correlations between in vitro Caco-2 and in vivo human intestinal 
permeability measurements were observed for some passively 
absorbed drugs [38], [39]. Since then, Caco-2 has been used to 
screen the intestinal permeability of an increasingly diverse 
population of compounds. Yee [40] had reported that Caco-2 may 
accurately predict the human intestinal permeability or absorption 
of compounds regardless of transcellular, paracellular, and carrier-
mediated transport mechanisms. However, there are Caco-2 
permeability results that disagree with measured human intestinal 
permeability rates or measured extents of human intestinal 
absorption [41], [42]. 
 
HeLa 
HeLa was the first human cell line established [43] and has then 
become the most widely used human cell line in biological 
research. Its application as a model of living organism has 
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contributed to the characterization of important biological 
processes described in more than 70000 publications. This cell line 
originates from a cervical cancer tumour of a patient named 
Henrietta Lacks, who died of cancer in 1951 [44]. One of the 
earliest uses of HeLa cells was to develop the vaccine against the 
polio virus [45]. 
The HeLa cells has contributed to many fundamental scientific 
breakthroughs, these cells have been employed to investigate 
cancer, AIDS mechanisms [46], and the effects of drugs, toxins and 
radiation [47]. These cells have also been used in the Nobel-
winning experiments that led to the discovery of telomeric activity 
[48]. 
Furthermore, to verify the gene-editing effects involved in specific 
cellular processes, gene expression profiles and proteome analyses 
have been applied to HeLa cells [49]. The widespread use of this 
cell line is mainly due to the easy handling and manipulation in 
different conditions. 
Several published studies reported that HeLa cells are characterized 
by extensive chromosome instability. Cytogenetic analysis of HeLa 
led to observe numerous chromosome aberrations, and extensive 
chromosome instability. 
HeLa cells have a hypertriploid (3n+) karyotype and produce 
heterogeneous cell populations [50], [51]. These cells differ in both 
their total number of chromosomes and in the number of specific 
chromosomes [52]. When Chu and colleagues examined parental 
HeLa cell lines and a series of clones derived from the primary 
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cells, they found wide variation in modal chromosome numbers 
[53]. Ghosh and colleagues [54] observed variation of stemline 
karyotype and rise of stable independent karyotype subpopulations 
from the "HeLa cell line (modal number 69)". Similarly, Macville 
and colleagues reported that 60% of the parental HeLa cells have a 
modal chromosome number of 78, and noted the emergence of a 
phenotypically distinct subpopulation of cells with their own stable 
karyotype (N=73) [55], [56]. 
 
Treatments 
 
Cadmium 
Cadmium is a highly persistent pollutant harmful to humans and 
animals, listed as one of the top ten hazardous substances by the 
Agency for Toxic Substances and Disease [57].  
The long biological half-life of cadmium makes it a cumulative 
toxin, so long past exposures could still result in direct toxic effects 
of the residual metal [58]. Unfortunately, there are no proven 
effective treatments for chronic cadmium intoxication [58]. The 
long residence time of cadmium is due to metallothionein (MT), a 
metal-binding protein that is induced at the transcriptional level by 
cadmium and strongly binds the metal [59]. Cadmium accumulates 
mainly in the liver where it is bound to metallothionein [60]. The 
body has limited capacity to respond to cadmium exposure, as the 
liver cannot transform the metal to a less toxic species and it is only 
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poorly excreted, making long-term storage a viable option to 
reduce toxic effect with this toxic element. 
Cadmium and its inorganic compounds were currently classified as 
a Group 1 carcinogen for human by IARC (International Agency 
for Research on Cancer) [61]. There was strong evidence specially 
based on experimental studies regarding cadmium carcinogenicity 
[62]. Cadmium is able to produce malignant tumours in multiple 
organs following long term and chronic exposure [59]. Besides 
experimental studies, epidemiological studies have also confirmed 
the potential cadmium carcinogenicity [63]. 
Although cadmium can produce genotoxic and mutagenic events, 
these generally require high doses [59]. Cadmium will not form 
stable DNA adducts and, since it is not a redox active metal, 
indirect oxidative DNA damage is unlikely as a primary 
carcinogenic mechanism. Thus, epigenetic non-genotoxic or 
indirect genotoxic mechanisms may apply. Such mechanisms could 
include aberrant gene expression resulting in stimulation of cell 
proliferation or blockage of apoptosis. Both these potential 
mechanisms could result in carcinogenic transformation in the 
absence of cadmium-induced genetic damage. Alternatively, 
cadmium can inhibit repair of DNA [64] which could be an indirect 
source of mutational events. Together with upregulation of 
mitogenic signalling, perturbed DNA repair and the resulting 
indirect genotoxicity could be key events in carcinogenesis [65]. 
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Gold nanoparticles 
Recent advances in material science have resulted in the creation of 
particles in the nano-scale range. However, years of research in this 
field, coupled with technological advances, have brought 
transformation in nanomaterial (NM) synthesis capabilities [66]. 
The consequent needs to assess the safety of NMs and identify their 
cellular responses have given rise to the field of nanotoxicology, 
which has now been in existence for over a decade [67]. 
The observed cellular reactions associated with NM exposure have 
identified a differential response that can be directly linked to their 
distinct physicochemical parameters [68], [69], demonstrating that 
small changes in NM properties can alter subsequent behaviour and 
cellular interactions. In addition to identify the NM properties that 
induce cytotoxicity, current investigations are in progress to 
evaluate the mechanisms behind these responses. Results of these 
inquiries have found that excess production of stress response and 
modifications to protein and gene expression precedes cellular 
death [70], [71]. 
Gold belongs to the group of noble metals and has been used in 
medical applications for centuries [71]. In recent years, nano-gold 
based applications were designed and gold nanoparticles (AuNPs) 
were synthesized with the idea that noble metal characteristics of 
gold would be preserved even when synthesized and used at nano-
scale, thus being bio-compatible [72]. AuNPs and their derivatives 
undergo continuous development for their use in clinical 
diagnostics, as drug delivery systems or therapeutic agents [73]. In 
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general, AuNPs are well tolerated in vivo [74], although some 
toxicity of AuNPs was also reported in vitro [75], [76]. 
 
Hypoxia 
Hypoxia and activation of hypoxia signalling pathways are 
associated with aggressive malignancy. Hypoxia inducible factor 
(HIF) is the key transcription factor mediating responses to 
hypoxia. Many common genes are among HIF target genes and 
genes implicated in dysregulated tumour metabolism. 
Hypoxia inducible factor-1 (HIF-1) was initially identified as a 
transcriptional regulator that is bound to the hypoxia-response 
element of the erythropoietin [77]. It was initially believed that the 
entire underlying oxygen sensing apparatus was only involved in 
the regulation of erythropoietin. Later studies of the hypoxia-
response element showed that the response pathway operated much 
more widely [78]. Consequently it became clear that HIF-1 has a 
wide range of transcriptional targets [79]. 
The Hypoxia inducible factor (HIF) senses and modulate cellular 
responses to hypoxia. HIF is a heterodimer: one of three alpha (α) 
subunits and a beta (β) subunit. HIF-β is constantly expressed, 
instead HIF-α is induced by hypoxia. HIF-1α is the most well-
established member of the HIF family; the other two members of 
the basic–helix–loop–helix-PAS (bHLH-PAS) superfamily are 
HIF-2α (endothelial PAS domain protein 1 or HIF1α-like-factor), 
which also stabilizes hypoxia and binds to the aryl hydrocarbon 
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receptor nuclear translocator (ARNT) and HIF-3α [80]. HIF-1α is a 
transcriptional activator and a master regulator for the expression 
of genes involved in the response to hypoxia in most mammalian 
cells [81]. 
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Cadmiumand cadmiumcompounds are contaminants of the environment, food, anddrinkingwater and are important constituents
of cigarette smoke. Cd exposure has also been associated with airborne particulate CdO and with Cd-containing quantum dots in
medical therapy. Adverse cadmium eTects reported in the literature have stimulated during recent years an ongoing discussion to
better elucidate cadmiumoutcomes at cell andmolecular level.Jepresentwork is designed to gain an insight into themechanismof
p53 impairment at gene and protein level to understand Cd-induced resistance to apoptosis. We used a hepatoma cell line (HepG2)
derived from liver, known to be metal responsive. At genotoxic cadmium concentrations no cell cycle arrest was observed. Je
p53 at gene and protein level was not regulated. Fluorescence images showed that p53 was correctly translocated into the nucleus
but that the p21Cip1/WAF-1, a downstream protein of p53 network involved in cell cycle regulation, was not activated at the highest
cadmium concentrations used. Je miRNAs analysis revealed an upregulation of mir-372, an miRNA able to aTect p21Cip1/WAF-1
expression and promote cell cycle progression and proliferation.Je role of metallothioneins and possible conformational changes
of p53 are discussed.
1. Introduction
Cadmium (Cd) is a toxic element present in air, soil, sedi-
ment, and water. It is released into the environment through
the waste from heavy metal mining, manufactures of nickel-
cadmium batteries, and from other industrial and agricul-
tural activities. It is ubiquitously present in the environment
and in food, thus leading to a potential risk of human
exposure. Nonoccupational exposure is mainly from diet and
smoking, due to an accumulation of Cd in tobacco plants [1].
More recently, Cd exposure has been associatedwith airborne
particulate CdO and with Cd-containing quantum dots in
medical therapy [2, 3]. Targets of Cd toxicity include liver,
lung, kidney cortex, bone, the cardiovascular system, and the
immune system ([4], see the reviews [5–7]).
Cd and Cd compounds have been classiaed as human
carcinogens (Group 1) by the World Health Organization’s
International Agency for Research on Cancer [8] and by
the National Toxicology Program [9]. Although Cd carcino-
genicity has been recognized by epidemiological studies and
animal experiments, the underlying mechanisms are still
matter of research activities. Proposedmechanisms have been
recently reviewed [10, 11] and range from thiol-containing
protein aTection and consequent production of reactive oxy-
gen species, and interference with essential metals. Moreover,
the deregulation of the cellular response to DNA damage
and the resistance to apoptosis are among other proposed
mechanisms involved in Cd-induced carcinogenicity [5].
Je tumor suppressor protein p53 is a crucial component
of the cellular response to DNA damage, and it is primarily
involved in defensemechanisms by transcriptional activation
of genes responsible of growth arrest and apoptosis for the
elimination of heavily damaged cells. Je inactivation of
p53 is one common feature found in human cancers [12].
Cd has been demonstrated to interfere with the structure
and function of p53 [5], although opposite eTects have been
reported. Namely, some authors refer to the induction of the
p53-mediated stress response [13], while others demonstrated
an inactivation of p53 via structural changes [14].
In this study we focused on the p53 pathway at gene
and protein level to better investigate the involvement of
this tumor suppressor protein in Cd-induced carcinogenesis.
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A microRNA analysis was further performed to evidence
a possible role of these small and noncoding regulatory
molecules.
We used the HepG2 cells as a model of human origin
from a target organ. Ae HepG2 cells are able to form struc-
tures typical of normal hepatocytes, express liver-speciDc
functions, are metal responsive, and, more in general, are
well characterized, thus making them a useful model for
mechanistic studies on Cd carcinogenicity [15–19].
2. Materials and Methods
2.1. Cell Line and Culture Conditions. HepG2 cells were
routinely grown in a monolayer culture in the presence of
Opti-MEMmedium (Invitrogen, San GiulianoMilanese, MI,
Italy) supplemented with 10% heat inactivated fetal bovine
serum (Invitrogen) and 1% antibiotics. Ae cells were main-
tained in an incubator at 37∘C and humidiDed atmosphere
of 5% CO2. Ae medium was replaced twice a week and
the cells were trypsinized and diluted every 7 days at 1 : 3
ratio. Ae cells were transferred either into 165 cm2 Yasks
(Costar, Euroclone, Pero, MI, Italy) for protein preparations
and cell cycle analysis, or into 8 cm2 plastic dishes (Costar)
for immunoYuorescence analysis. Cells grown in complete
culture medium represented the controls. A 1mM stock
solution of CdCl2 monohydrate 97% purity (Cd, BDH Italia,
Rome, Italy) was prepared in sterile MilliQ water (Millipore,
Vimodrone, MI, Italy), and further dilutions were prepared
in complete culture medium just before use.
2.2. Cell Cycle Analysis. Ae cells were seeded (7 × 105
cells/Petri dishes) and treated (10휇M Cd, 24, 48, and 72
hours) 24 h acer seeding. Treated and control cells were har-
vested by trypsinization, collected by centrifugation (200 g,
5min), and washed in PBS. Ae samples were further cen-
trifuged (200 g, 5min) to remove the PBS, Dxed in cold
ethanol, and stored at −20∘C until use. Defrosted samples
were centrifuged (200 g, 10min) to remove ethanol and were
incubated (15min) for RNA hydrolysis and DNA staining
using the DNA Prestain kit (Coulter Reagents, Beckman
Coulter). Cell cycle distribution was analyzed by Yow cytom-
etry (Becton Dickinson Italia, Buccinasco, MI, Italy). Ae
percentage of cells in each phase was estimated by FlowJo
socware using the Dean-Jett-Fox best Dt and compared to
untreated control cells.
2.3. p53 Extraction and Immunochemical Analysis. HepG2
cells (5 × 106 cells/Yask) were exposed to increasing Cd
concentrations (0.1–10휇M) for 24 h. At the end of the
exposure time, the cells were harvested by trypsinization,
collected by centrifugation (200 g, 10min), and washed with
PBS to remove Cd excess. Ae cells were collected again
by centrifugation (200 g, 10min), and homogenates of total
proteins were obtained by resuspension in sample bufer
(0.05M Tris-HCl, pH 6.8, containing 2% SDS, 10% glycerol,
10% 훽-mercaptoethanol) containing 1mM PMSF freshly
added prior use. Homogenates were boiled for 5min, passed
3-4 times through a syringe needle (22 ga Ø), and stored at
−80∘C until use. Total protein content was estimated by the
Lowry method [20] using BSA as a standard.
Ficy휇g of total proteins was separated on 10% NuPAGE
gels (Invitrogen) in MOPS running bufer (Invitrogen, cat.
number NP0001) and transferred onto a nitrocellulose mem-
brane and processed for immunochemical analysis. A p53
monoclonal antibody (StressGen, Vinci-Biochem, Vinci, FI,
Italy) was used, and the membrane incubation was run
overnight at 4∘C. Acer incubation with the secondary anti-
body (mouse IgG alkaline phosphatase conjugate, Sigma), the
speciDc bands were visualized by the colorimetric substrates
BCIP/NBT (Fast, Sigma).
2.4. p53 Immuno=uorescence Localization. HepG2 cells were
plated (100.000 cells/cm2) on glass coverslips and lec to
recover at 37∘C in incubator. Ae next day, the cells were
treated with Cd (2, and 10 휇M) for 24 h. Acer treatment,
the cells were rinsed with PBS, Dxed with methanol (5min,
−20∘C), and processed for immunoYuorescence labeling of
the p53 protein. Primary antibody mouse anti-p53 (Sterss-
Gen) at 1 : 50 dilution in PBS + 1% BSA was used, and the
cells were incubated for 1 h at 37∘C. Acer saturation with PBS
and PBS + 1% BSA, the cells were labeled with 1 : 100 Alexa
Fluor 594 (Molecular Probes, Invitrogen) and incubated for
45min at 37∘C in humidiDed atmosphere.Aen, sampleswere
washed in PBS and distilled water, stained with DAPI (4耠,6-
diamidino-2-phenylindole) for nuclei visualization, and air-
dried prior mounting. Ae coverslips were viewed on a Zeiss
Axioplan microscope equipped with epiYuorescence optics
and a digital camera (CoolSnap-ProColors Media Cybernet-
ics, Bethesda, MA, USA), and images were taken and stored
using the Image Proplus socware (Media Cybernetics).
2.5. 푝21퐶푖푝1/푊퐴퐹-1 Immunochemical Analysis. HepG2 homo-
genates obtained as described in par.2.4were used to evaluate
the p21Cip1/WAF-1 expression in Cd-treated cells (0.1–10 휇M).
Ficy휇g of homogenated proteins was separated by elec-
trophoresis in 12% NuPage gels (Invitrogen) and processed
as previously described [16] to enhance membrane transfer
and retention of low molecular weight proteins. Mouse anti-
p21Cip1/WAF-1 was used as a primary antibody (Invitrogen).
Anti-mouse alkaline phosphatase conjugate (Sigma, St. Louis,
MO, USA) was used as a secondary antibody, and pro-
tein binding was visualized by the colorimetric substrate
BCIP/NBT (Sigma-Aldrich, Milano Italy).
2.6. MicroRNA Expression ProEling. RNA was extracted
using the MIRVANA kit (AMBION) according to the manu-
facturer’s instructions. Concentration and quality were deter-
mined by Nanodrop. Total RNA was reverse transcribed
with Taqman MicroRNA Reverse Transcription Kit using
Megaplex RT Primers (Applied Biosystems). Real-time PCR
reactions were carried out on preconDgured microYuidic
cards (TaqmanArrayMicroRNACards, set A, V2.2 and set B,
V3, Applied Biosystems) allowing the detection of about 754
unique assays speciDc and four candidate endogenous control
assays.
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Two biological replicates for control and two for 10 휇M
Cdwere tested. Experimental data were then analyzed by SDS
2.3 soCware (Applied Biosystems) and the relative expression
values were calculated using as endogenous control U6 for
miRNA. MiRNAs with a threshold cycle <33 that showed
a log fold change greater than one in samples treated with
cadmium as compared to control samples were considered as
induced.
2.7. Statistical Analysis. Student’s 푡-test or ANOVA (multiple
range test) was used for comparisons. Pe soCware package
Statgraphics Plus version 5.0 (Statistical Graphics Corp.,
Manugistic Inc. Rockville, MD, USA) was used for the
statistical analysis.
3. Results
3.1. Cell Cycle Progression Is Not A7ected by Cd Exposure
in HepG2 Cells. We previously demonstrated by MTT assay
that Cd concentrations used in the present work induce a
maximum of 20% loss of viability at 10 휇MCd.Pe IC50 value
(50% of the reduction of cell viability) was computed to be
25.5 휇M [16].
Cadmium induces DNAdamage inHepG2 cells, as previ-
ously reported [22, 23], and as con[rmed by our experiments
on single-strand breaks formation (data not shown).
In the presence of DNA damage (e.g., single strand
breaks), the cell systemshave evolvedmultiplemechanisms to
avoid damage propagation. Among these, responses working
inmammalian cells include the cell cycle check points control
mechanisms, as well as apoptosis for the elimination of
heavily damaged cells.
Our results showed that in HepG2 cells exposed to the
highest Cd concentration (10 휇M) for di\erent time points
(24, 48, and 72 h), there was no e\ect on cell cycle pro-
gression. Pe distribution of cell population among the cell
cycle phases (G1, S, G2/M) did not change when statistically
compared to controls (Figure 1(a)), even aCer 72 h of Cd
exposure (Figures 1(a) and 1(b)).
3.2. p53 Expression and Localization in Cd-Stressed HepG2
Cells. Pe p53 tumor suppressor protein is a key regulator of
cell cycle arrest and of apoptosis. In response toDNAdamage,
the p53 is normally activated and accumulated to exert its
DNA-binding activity for the regulation of genes involved
either in G1 cell cycle arrest or apoptosis. To understand the
mechanism behind the cell cycle progression in the presence
of a genotoxic e\ect of Cd, we analyzed the p53 expression.
At molecular level, we focused on the genes related to the p53
signalling pathway. Interestingly, the map of KEGG shows
that the p53 gene was not regulated at the transcriptional
level (Figure 2). At protein level, immunochemical results
con[rmed that there is no clear evidence of an upregulation of
this transcription factor in Cd-exposed (0.1–10 휇M) samples
(Figure 3).
We next analyzed the subcellular localization of p53 by
indirect immunoduorescence in the presence of genotoxic
Cd concentrations (2 and 10휇M) to verify whether the
p53 was correctly localized to exert its function. Fluores-
cence images showed that in control cells the p53 signal
is spread and localizes throughout the cytoplasm (Figures
4(a)–4(c)). In cells treated with DNA-damaging concen-
trations of Cd (2 and 10 휇M), the p53 duorescence signal
is increasingly concentrated and accumulated in areas that
co-localize with the nuclei (Figures 4(d)–4(f) and 4(g)–
4(i)), as expected by a transcription factor. To quantitatively
express the nuclear localization of the p53, a wide population
(400–1000 cells/controls or Cd) of stained cells coming
from independent experiments and di\erent coverslips was
counted. In controls only 10 ± 3,2% of the cells showed a
p53 nuclear localization, con[rming the predominant cyto-
plasmic distribution in unstressed cells, while in Cd-treated
samples an increasing percentage of the cells showed that
the transcription factor moves into the nucleus (Cd 2 휇M
30 ± 9,2%, and Cd 10 휇M 67 ± 18%) to activate downstream
genes. Pe extent of p53 nuclear localization in controls and
in Cd-treated cells is summarized quantitatively in Figure 5.
3.3. 푝21퐶푖푝1/푊퐴퐹-1 Levels in Cd-Stressed HepG2 Cells. To
better understand the p53 pathway and regulatory activity, we
have analyzed the expression of the p21Cip1/WAF-1 protein.Pe
p21Cip1/WAF-1 is a downstream protein known to be regulated
also by p53 to trigger cell cycle arrest in DNA damaged cells.
At gene level, p21Cip1/WAF-1 was upregulated, as shown by the
p53 signalling pathway (Figure 2, in red). Nevertheless, levels
of p21Cip1/WAF-1 protein were comparable to controls at the
lower Cd concentrations and decreased at 5 and 10 휇M Cd
(Figure 3).
3.4. miRNA Modulation. We have analyzed the modulation
of these small and noncoding molecules, acting at posttran-
scriptional level, to unravel the apparent contrast between the
p21 gene upregulation and the p21 protein downregulation at
high Cd concentrations (5 and 10휇M).
Pe e\ects of 10 휇M Cd on miRNAs were evaluated with
microduidic cards and the focus was on the upregulated
miRNAs. In Cd-treated samples we identi[ed two miRNAs
that were upregulated: hsa-mir-138 and hsa-mir-372.
4. Discussion
Pe aim of this study was to investigate the role of the
p53 tumor suppressor at gene and protein level in order to
contribute to the comprehension of the reported resistance to
apoptosis in Cd-treated cells [5]. Cadmium carcinogenicity
has been recognized by epidemiological studies and animal
experiments, as recently reviewed [6, 8]; however, the overall
mechanism is still unclear. In addition, condicting results
concerning the e\ects of Cd on biological systems are present
in the literature [13, 14], possibly justi[ed by a recently
demonstrated hormetic e\ect of this metal [24, 25]. Current
evidence suggests that Cd carcinogenicity is not due to
a direct genotoxic e\ect of this metal. Multiple indirect
mechanisms, the interference with the cell response to DNA
damage, the deregulation of cell growth, and the resistance to
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Figure 1: E:ects of CdCl2 on cell cycle distribution of HepG2 cells. HepG2 cells were cultured in the presence of 10휇M Cd concentration
for di:erent time points (24, 48, and 72 h). (a) Qe distribution of the cell population in the di:erent cell cycle phases of treated cells (black
bar) is always comparable to controls (grey bar) at all tested time points. In (b) an example of histogram obtained by Sow cytometer analysis
is displayed; the DNA content (푥 axis) is plotted against the cell number (푦 axis). Cells from three independent experiments were analyzed.
apoptosis aremore accreditedmechanismswhich account for
Cd carcinogenicity [5, 7, 11].
In HepG2 cells and, more in general, in mammalian
cells cadmium exerts the genotoxic e:ect through reactive
oxygen species generation, causing DNA strand breaks and
chromosomal aberrations ([22], for a review see [5]). Qe
DNA damage response is rigorously coordinated by multiple
mechanisms, among which the p53 has a key role. Qe p53 is
essential in the regulation of the cell cycle arrest and apoptosis
for the processing of DNA damage and for restoring genomic
stability or eliminating heavily damaged cells [26]. Our
experiments demonstrated that in Cd-treated HepG2 cells,
these regulatory mechanisms were not activated. Namely, no
cell cycle arrest was induced at the highest Cd concentration
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Figure 3: EOect of CdCl2 on p53 and p21Cip1/WAF-1 protein expres-
sion. HepG2 homogenated proteins (50 휇g/lane) were separated on
12% gels or 10% gels, transferred onto nitrocellulose membrane,
and probed for p21Cip1/WAF-1 or p53 protein expression, respectively.
Representative Western blots are shown. Parallel gels stained with
Coomassie Blue G250 for equal protein loading evaluation were
performed.
tested (10 휇M), and no p53 upregulation was observed, as
visualized at gene as well as at protein level. In response to
stress, the p53 is normally accumulated in the nucleus and
converted into an activeDNA-binding form to control several
sets of genes to prevent the proliferation of cells carrying a
DNA damage [27]. To the best of our knowledge, our results
of buorescencemicroscopy show for the Grst time that the p53
was increasingly accumulated into the nucleus in Cd-treated
HepG2 cells, according to the activity of a transcription factor.
However, despite this correct localization in stressed cells,
the p53 was not able to activate the downstream signals of
cell cycle regulation and arrest to allow the DNA repair.
Eis data is supported by the result on the p21Cip1/WAF-1,
a p53 downstream protein responsible for the cell cycle
arrest [26]. Indeed, in our samples the p21Cip1/WAF-1 showed
levels comparable to controls or downregulated in Cd-treated
HepG2. Eerefore, this lack of regulation could account for
the normal progression of the HepG2 cells into the cell cycle
phases that we observed.
Ee uncontrolled proliferation of DNA-damaged cells
and the acquisition of apoptotic resistance are important
steps in themalignant transformation process. In this context,
our results on the impairment of p53 pathway activity go
through this direction. HepG2 cells, albeit derived from a
human hepatoma, express a wild type and an inducible p53
activity, well documented previously [28]. However, previous
works [3, 14] suggest that this activity could be impaired
by conformational changes in the wild type p53 protein, as
demonstrated inMCF7 andA549 cells exposed to soluble and
particulate Cd compounds. Ee impairment of p53 activity
could also be explained by our recent Gndings on microRNA
(miRNA) levels in Cd-exposed HepG2 [29].EemiRNAs are
small and noncoding RNAs which play a key role in gene
expression at the posttranscriptional level, targeting mRNAs
for cleavage or translational repression. We previously found
that a large percentage of downregulated miRNAs belong
to the let-7 family. Ee let-7 family is reported to have
oncosuppressor functions as it regulates processes including
cell division andDNA repair. In this regard, very interestingly
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Figure 4: Visualization of p53 localization in CdCl2-treated HepG2 cells. Fixed and p53 stained cells were visualized by indirect probing
with Alexa Fluor antibody. In control HepG2 (a), a spread distribution of the p53 is shown throughout the cells, while the treatment with Cd
increases the nuclear localization of the protein (d, g). (a, d, g) cells probed for p53 in controls (a), 2 휇M (d), and 10휇M (g) Cd concentrations.
(b, e, h) cells stained with DAPI for the nuclei visualization in controls (b), 2휇M (e), and 10휇M (h) Cd concentrations. Merge is represented
in (c, f, i) images. Microscopy magniWcation: 400x.
it was recently described [30] that let-7a and let-7b expression
are dependent on the p53 activity. Moreover, miRNAs are
reported to have control activities on p21 at posttranscrip-
tional level [31, 32] further sustaining our data on p21
expression at gene and protein level. Indeed, we suggest that
the apparent contrast between p21Cip1/WAF-1 upregulation at
gene level and no modulation or downregulation at protein
level could be possibly explained by the posttranscriptional
activity of miRNAs. [ese Wndings support our data on the
impaired function of this transcription factor. In order to
further explain the lack of regulation of the p53 we analyzed
the miRNA expression in Cd-treated HepG2. We analysed a
panel of miRNA regulated upon stimulation of Cd, and we
identiWed that two were upregulated a^er Cd exposure: mir-
372 and mir-138, both connected to carcinogenesis [33, 34].
Wu and colleagues [32] showed that mir-372 can bind to the
3’UTR of p21Cip1/WAF-1 abecting its expression. Furthermore,
the expression of mir-372 can promote cell proliferation and
cell-cycle progression [34].[is mechanism warrants further
investigation, but the work by Wu and colleagues together
with our data on mir-372 upregulation provides hints on
the involvement of miRNAs in the toxic mechanism induced
by cadmium promoting proliferation activities. [e second
miRNA that we found upregulated, mir-138, was recently
described to have oncosuppressor functions and its down-
regulation was associated with head and neck squamous cell
carcinoma (HNSCC). However, while the deregulation of
miR-138 is frequently observed in HNSCC and other cancer
types, the exact role of miR-138 in tumorigenesis remains
elusive [33]. [us further functions and regulatory activities
of this miRNA need to be deeply depicted.
Another possible mechanism that could contribute to
the impairment of p53 activity and subsequent inhibition
of the cell cycle arrest in HepG2 cells is the interference of
metallothioneins (MTs).[e expression and induction of this
low molecular weight family of proteins are associated with
protection against oxidative stress, cytotoxicity, and DNA
damage. Cd is a transcriptional modulator, among others,
of MT gene expression, and this family of metal-binding
proteins appears also to play a key role in the prevention of
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Figure 5: Quanti:cation of the p53 nuclear localization. Percentage
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control: ∗푃 < 0.5; signi:cantly diWerent between Cd treatments:
#푃 < 0.05.
apoptosis, acting as regulators of p53 folding and activity [35].
In addition, MT null cells are more susceptible to apoptotic
death a[er exposure to apoptosis-inducing agents, and the
involvement of MT in controlling apoptotic mechanisms was
suggested in the past [36].MTswere also proposed as proteins
involved in the regulation of p53 stability and DNA-binding
activity, along with a protective function in Cd-induced
toxicity [37]. In HepG2 cells, MTs are strongly upregulated in
the presence of Cd, as previously demonstrated by our group.
[16, 21, 38].Sese data sustain the speculation of a role forMT
as negative regulators of apoptosis and of p53 activity [35].
5. Conclusions
In conclusion, as depicted and summarized in Figure 6, we
demonstrated for the :rst time that in HepG2 cells exposed
to Cd, the p53 was correctly moved and accumulated into
the nucleus to exert its function of transcription factor.
However, besides this correct nuclear localization, the signals
for the cell cycle arrest were not activated. In this context, the
p21Cip1/WAF-1, a p53 downstream protein and an important
mediator of cell cycle arrest, was upregulated at gene level
but not at protein level. Sese results could be explained by a
posttranscriptional activity by the miRNA, as demonstrated
by the upregulation of mir-372 in Cd-treated HepG2 cells,
able to aWect p21Cip1/WAF-1 expression and to promote cell
proliferation. In this complex network, it seems of cru-
cial importance to further investigate the relation between
miRNA activity and p53 impairment.
Se inauence of Cd on p53 inactivation by conforma-
tional changes is under investigation by our group to more
Cd
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p53
Cell cycle 
progression
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Figure 6: Overview of cadmium eWects. (1) Cadmium is accumu-
lated into HepG2 cells [21] and indirectly causes a genotoxic damage
[22, 23] (data not shown); (2) the p53 is visualized into the nucleus,
as expected, to exert its function of transcription factor; (3) the
p21Cip1/WAF-1 gene (p21 mRNA) is upregulated, although no protein
upregulation is observed possibly due to a posttranscriptional
regulation by miRNA-372; (4) no cell cycle arrest is observed, thus
leading to the transmission of DNA damage and ultimately to
cancer.
deeply elucidate the apoptotic resistance and the mechanism
of Cd-carcinogenicity. Our results support the hypothesis of
Cd as a double-edge sward factor [11], as it induces DNA
damage and inhibits its repair.
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 Biological effects (toxicity, uptake and changes in gene expression patterns) on Caco-2 cells of citrate-stabilized 5nm and 30nm AuNPs were compared.
 Exposure to 5nm AuNPs had much stronger effect on gene expression as compared to treatment with 30nm AuNPs.
 Nrf2 signaling stress response was among the highly activated pathways.
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A B S T R A C T
Higher efficacy and safety of nano gold therapeutics require examination of cellular responses to gold
nanoparticles (AuNPs). In this work we compared cellular uptake, cytotoxicity and RNA expression
patterns induced in Caco-2 cells exposed to AuNP (5 and 30nm). Cellular internalization was dose and
time-dependent for both AuNPs. The toxicity was observed by colony forming efficiency (CFE) and not by
Trypan blue assay, and exclusively for 5 nm AuNPs, starting at the concentration of 200mM (24 and 72h
of exposure). The most pronounced changes in gene expression (Agilent microarrays) were detected at
72h (300mM) of exposure to AuNPs (5 nm). The biological processes affected by smaller AuNPs were:
RNA/zinc ion/transition metal ion binding (decreased), cadmium/copper ion binding and glutathione
metabolism (increased). Some Nrf2 responsive genes (several metallothioneins, HMOX, G6PD,
OSGIN1 and GPX2) were highly up regulated. Members of the selenoproteins were also differentially
expressed. Our findings indicate that exposure to high concentration of AuNPs (5nm) induces metal
exposure, oxidative stress signaling pathways, and might influence selenium homeostasis. Some of
detected cellular responses might be explored as potential enhancers of anti-cancer properties of AuNPs
based nanomedicines.
ã 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Nanotechnology and nanomedicine bring novel approaches
into clinics, revolutionizing diagnosis and treatment options for
diverse groups of patients. Engineered nanomaterials (ENMs) are
also widely used in other consumer products and applications
increasing the likelihood of human exposure to nanomaterials
(Staggers et al., 2008). The exposure to ENMs can take place not
only during their synthesis, production and usage, but also at other
stages of the life cycle (e.g., waste deposition/combustion, material
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recycling) of a given nanomaterial. Therefore, in order to assure the
safety of human population and environment, toxicological
profiling of cellular responses to ENMs and proper risk assessment
of nanomaterials should be performed (Maynard, 2012). The
(nano) toxicological hazard identification and characterization are
also required for improvement of the safety and efficacy of
nanomedicines, including nano gold based formulations used in
biomedical applications. Moreover, studies focused on the con-
sequences of the long-term exposures to ENMs, including gold
nanoparticles (AuNPs), are needed (Kunzmann et al., 2011).
Gold belongs to the group of noble metals and has been used in
medical applications for centuries (Bhattacharya and Mukherjee,
2008). In recent years, nano gold based applications were designed
and AuNPs synthesized with the idea that noble metal character-
istics (in bulk) of gold would be preserved even when synthesized
and used at nano scale, thus being bio-compatible (Connor et al.,
2005). AuNPs and their derivatives undergo continuous
development for their use in clinical diagnostics, as drug delivery
systems or therapeutic agents (Dykman and Khlebtsov, 2012). In
general, AuNPs are well tolerated in vivo (Hainfeld et al., 2006),
although some toxicity of AuNPs was also reported in vitro
(Pernodet et al., 2006; Chuang et al., 2013; Coradeghini et al., 2013;
Mironava et al., 2014).
As methodologies develop, “omics” based research platforms
can complement the classical tools for cytotoxicity testing in
(nano) toxicology field. Therefore, identification and characteriza-
tion of biological responses can be achieved at molecular levels
compromising biomarkers/endpoints that can include whole or
parts of transcriptome, proteome, metabolome, epigenome and/or
genome of the in vitro/in vivo system under investigation
(Hamadeh et al., 2002). Although toxicogenomics and other
“omics” methods are currently easily accessible and cost effective,
to date only a few studies applied transcriptomics or proteomics
tools in the study of AuNPs induced/mediated cellular responses
(Esther et al., 2005; Yang et al., 2010; Li et al., 2011; Qu et al., 2013;
Gioria et al., 2014).
All living organisms respond to diverse stress stimuli. Depend-
ing on the biological context of given exposure/stressor, its severity
and duration, cells within tissue/organ react to stimuli by evoking
stress or adaptation responses, or die (Fulda et al., 2010; Chovatiya
and Medzhitov, 2014). One of the key regulators of cellular
responses to endogenous and/or exogenous stress is the nuclear
factor E2-related factor 2 (Nrf2) protein. Nrf2 is a redox and
xenobiotics sensitive transcriptional factor, assuring the expres-
sion of proteins involved in cellular adaptation to oxidative stress,
adjustment of metabolism and detoxification of drugs (Kensler
et al., 2007). Under normal cellular conditions, Nrf2 functions as a
tumor suppressor. However, it has been shown that Nrf2 might
also act as an oncogene (Shelton and Jaiswal, 2013). Among gene
targets regulated by Nrf2 are metallothioneins (MTs), which are
small, cysteine rich and metal ion binding proteins. MTs play an
important role in the protection of cells against metal toxicity, but
are also involved in responses to oxidative stress, and exposure to
glucocorticoids and cytokines (Miles et al., 2000).
The aim of this study was to investigate how the colorectal
adenocarcinoma epithelial cell line (Caco-2), an in vitro model of
the intestinal route of exposure to nanoparticles, responds to
AuNPs treatments at RNA gene expression level. We selected
undifferentiated cells mainly because in this way we looked at
populations of heterogenic pool of Caco-2 cells prior to differenti-
ation, therefore having wider plasticity in the cellular physiology,
sensing and adaptation/response to stress, as compared to mature
and polarized enterocytes (Tadiali et al., 2002). Keeping this in
mind, when running both the cytotoxicity and RNA transcript
profiling experiments, we explored Caco-2 cells (in undifferenti-
ated stage) as potentially more suitable model for detecting
alterations in gene expression patterns upon exposure to NPs. For
that purpose, we tested citrate-stabilized spherical AuNPs of two
sizes (5 nm and 30nm, synthesized and characterized in-house)
for their cytotoxic potential, internalization and induction of
changes in mRNA and long non-coding RNAs expression patterns
using transcriptomics approach (Agilent microarrays platform).
The microarray data were further validated with quantitative
real-time reverse-transcriptase PCR (qPCR) for a set of mRNAs
which were differentially expressed upon exposure of Caco-2 cells
to AuNPs. Several biological pathways affected by treatment of
Caco-2 cells with AuNPs (5nm, 300mM, 72h) were identified in
microarray datasets using bioinformatical tools. The novelty of this
work is the integration of classical in vitro testing with the
chemico-physical characterization of NPs, Omics and advanced
analytical techniques to better understand the mechanisms of
potential nanomaterials’ toxicity. Their use has the potential to
provide a description of the bio-responses and allows highlighting
critical biochemical pathways affected by nanoparticle exposure.
Huge progresses have been made in the genomic field and here we
integrated this discipline to investigate in detail modifications
caused by AuNPs exposure at gene level. The results of this work
established a starting point in understanding and disseminating
which cellular processes can be linked to the observed cytotoxic
effect of 5 nm AuNPs on cancer Caco-2 cells.
2. Materials and methods
2.1. AuNPs synthesis and characterization
AuNPs of approximately 5nm and 30nm size in diameter
were synthesized and concentrated as described in literature
(Coradeghini et al., 2013; Turkevich et al., 1951). Detailed
description of the chemicals used for AuNPs synthesis, description
of the equipment used for particles size distribution and
characterization, sample preparation, image acquisition and
processing, can be found in Supplementary methods.
The stability of AuNPs dispersions was studied both using a
centrifugal particle sedimentation (CPS) instrument and by
zeta-potential measurements in representative media. Citrate-
stabilized AuNPs (5 and 30nm) were incubated at two different
concentrations (100 and 300mM) in three different media (milliQ-
water, serum-free cell culture medium and complete cell culture
medium). Measurements were made immediately after mixing
AuNPs samples with the corresponding medium (time 0) and then
again after 24 and 72h incubation times at 37  C.
AuNPs dispersions for cell exposure experiments were freshly
prepared by diluting the AuNPs suspensions (after concentration
step, as described in the Supplementary methods) in complete
culture medium, and were added directly to Caco-2 cell cultures.
The concentration step produced two solutions containing all the
reagents used for the NPs synthesis and they were used as solvent
controls for biological testing.
2.2. Cell culture
Human epithelial colorectal adenocarcinoma cells (Caco-2) are
from the European collection of cell cultures (ECACC) and were
purchased fromSigma (Catalogue number: 86010202; passage 45).
Experimental cultures were prepared from deep-frozen stock vials
and maintained in a sub-confluent state. They were grown in
complete cell culturemedium composed of high glucose (4.5 g/mL)
Dulbecco’s modified Eagle medium (DMEM), supplemented with
10% (v/v) fetal bovine serum (FBS), 4mM L-glutamine and 1% (v/v)
pen/strep (all from Invitrogen, Italy). Cultures were maintained in
cell culture incubator (HERAEUS, Germany) under standard culture
conditions (37  C, 5% CO2 and 95% humidity). Caco-2 cells used in
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this work were screened for the presence of Mycoplasma with
quantitative PCR (qPCR) using the Venor1GeM Prime kit and were
Mycoplasma free.
2.3. Cytotoxicity assays
Cytotoxic effect of AuNPs in Caco-2 cells was studied by colony
forming efficiency (CFE) and Trypan blue exclusion assays.
For the CFE, cells were seeded at the density of 200 cells per
60 15mm dish (Corning, Italy) in 3mL complete culture medium
(three replicates) for each treatment. Twenty four hours after
plating, the medium was changed and 3mL of fresh medium
containing the AuNPs was added to obtain the final AuNP
concentrations of 10, 50, 100, 200 and 300mM corresponding to
0.02, 9.85, 19.70, 39.40 and 59.10mg/mL, respectively. After 24 and
72h of exposure, the medium was replaced with fresh complete
culture medium. On the 13th day from seeding, cells were fixed
with 3.7% (v/v) formaldehyde solution (Sigma–Aldrich, Italy) in
phosphate-buffered saline (PBS) without calcium, magnesium and
sodium bicarbonate (Invitrogen, Italy) and stained with 10% (v/v)
Giemsa GS-500 solution (Sigma–Aldrich) in ultra pure water.
Solvent controls (cells exposed to two different solvents obtained
after AuNPs of 5nm and 30nm filtration, as used for the highest
concentration tested) and a positive control (1mM) sodium meta
chromate (Sigma–Aldrich) were included. Colonies were scored
using a cell colony counter GelCount (Oxford Optronix Ltd., UK).
For Trypan blue exclusion assay, 2.5 105 and 0.9 105 cells
were seeded for 24h and 72h exposures, respectively, in 6 well
plates (Falcon, Italy) with 2mL of complete cell culture medium.
Twenty four hours after plating, cells were exposed to 50, 100 and
300mM of 5 and 30nm AuNPs, corresponding to 9.85, 19.70, and
59.10mg/mL. At the end of the exposure time (24 or 72h), cells
were washed twice with PBS, detached with 0.5mL of 0.05%
trypsin sodium ethylene diamine tetraacetic acid (Trypsin-EDTA)
from Invitrogen, and harvested with 1mL of complete culture
medium. Next, 30mL of each sample was stained with 30mL of
Trypan Blue (Sigma–Aldrich) and cells were counted with the
TC10 automated cell counter (Biorad, Italy) according to the
supplier’s protocol. Negative control, solvent control and positive
control were also included in the test, as described for CFE assay.
In the CFE and Trypan blue assays, the results were normalized
to the solvent control. For the CFE assay, they are expressed as CFE
(%) ([average number of treatment colonies/average number of
solvent control colonies] 100). For the Trypan blue assay, they are
expressed as viability (%) ([number of cells in treatment/number of
cells in solvent control] 100). One-way analysis of variance
(ANOVA) with post-hoc test (Dunnett’s multiple comparison test)
for comparing groups of data against one control group was used.
Data are reported as mean values !SEM (standard error
mean= standard deviation/
p
number of replicates). The data
represents mean value of three independent biological replicas,
where p values of less than 0.05 (*) and 0.001 (***) were considered
statistically significant. Statistical calculations were carried out
using GraphPad Prism Version 5.0 (GraphPad Software, USA).
2.4. Nanoparticle internalization
The uptake of AuNPs, their associationwith cellular membrane/
matrix and internalization were quantified by Inductively Coupled
Plasma Mass Spectrometry (ICP-MS). The uptake of AuNPs,
association of AuNPs with cellular membrane/matrix and the
internalization of AuNPs was quantified by ICP-MS. For the
ICP-MS, 7 105 and 3 105 CaCo-2 cells were seeded in dishes from
Corning (100mm 15mm) for 24 and 72h exposure time respec-
tively, in 5mL of complete culturemedium. Twenty four hours after
seeding, cells were treated for 24 and 72h with 5 and 30nm AuNPs
(100 and300mM).At the endof the exposure time, themediumwas
removed and collected for each sample, cells were washed twice
with PBS and eachwash collected in a separate tube. Cellswere then
detached with 1mL of Trypsin-EDTA (Invitrogen, Italy) and
harvested with 5mL of complete culture medium. After this, cells
suspension was centrifuged at 200 g for 5min (4 #C), and the
supernatantwas transferred intoanewtube. The cellular pelletwas
suspended in 1mL of culture medium. An aliquot of each sample
(20mL) was taken for cell count with TC10 automated counter. The
total content of Au in the cells (cellular pellet) as well as in all
the fractions collected fromeach cell culture sample: (i)medium at
the end of the treatment (24 and 72h), (ii) supernatants from the
two washes, (iii) cellular pellet, and (iv) the final supernatant
(representing a third wash), were analyzed by ICP-MS after
mineralization with Aqua Regia (HNO3:HCl at 1:3 ratio) and
microwave digestion (2 cycles at 950W for 10min) in a Discover-
Explorer microwave instrument (CEM Corporation, USA). These
extensive washing of cells and sample collection steps for Au
content measurements were applied to remove weakly bound
AuNPsand toassure that the total starting amountofAugiven to the
cells was recovered among different fractions (including both,
strongly associated with and/or internalized by cells and not taken
up by cells). Three independent experimental replicas were carried
out and the results were expressed as pg Au/cell, % of the external
exposure concentration and as a number of NPs/cell. Calculations
were performed as described in Coradeghini et al. (2013).
2.5. Exposures to AuNPs and RNA extraction
For the gene expression experiments, 2.5 105 and 0.9 105
Caco-2 cells were seeded in 2mL complete cell culture medium, in
a 6 well/plate (Falcon, Italy), and incubated for 24 and 72h with
5nm or 30nmAuNPs, at either 100 and 300mM concentrations. At
the end of the treatment, the exposure mediumwas removed and
cells were washed twice with PBS, and harvested with 300mL of
RLT plus RNeasy lysis buffer (Qiagen, USA). Cell lysates were
collected fromwells and stored at $80 #C until the RNA extraction
step was performed. The details of RNA isolation are available in
Supplementary methods.
2.6. Microarray expression profiling
The microarray (Agilent Whole Human Genome Oligo Micro-
array: 4 44k 60mer slide format) experiments were designed to
perform three biological replicates for each time point (24 and
72h), AuNPs size (5 and 30nm) and concentration (100 and
300mM)with completemedium and solvent controls. All the cRNA
synthesis/sample-labeling, hybridization, washing, and scanning
steps were conducted following the manufacturer’s specifications
(Agilent Technologies Inc., USA). Procedures for microarrays based
data generation are described in Supplementary methods.
2.7. Quantitative PCR validation of microarray data
A real-time quantitative PCR (qPCR) analysis has been done on
the same RNA samples that were used for the microarray
hybridization, with the aim to validate the microarray results.
All reagents for the qPCR and equipment were from Applied
Biosystems, USA. The details of qPCR validation process and data
analysis using delta–delta Ct method (Livak and Schmittgen, 2001)
are available in Supplementary methods.
2.8. Gene expression data analysis
Quality control and array normalization were performed in the
R statistical environment using the Agi4x44PreProcess (v 1.18.0)
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package, downloaded from the Bioconductor web site (Gentleman
et al., 2004). The normalization and filtering steps were based on
those described in the Agi4x44PreProcess reference manual.
Briefly, Agi4x44PreProcess options were set to use the mean
signal and the BG median signal as foreground and background
signals, respectively. Data were normalized between arrays by the
quantile method (Bolstad et al., 2003). In this approach, the
distribution of intensities of different microarray chips are
transformed to become equal so that intensities can be compared
between each other. In order to detect expression changes among
different treatment conditions, the moderated t test was applied.
Moderated t statistics were generated by Limma Bioconductor
package.Modulated geneswere chosen as thosewith a fold change
greater than 1.5 log2 fold change and a false discovery rate
(Benjamini and Hochberg’s method) corrected p-value smaller
than 0.05 (Smyth, 2004). Microarray results have been submitted
to NCBI’s gene expression omnibus (GEO) repository and are
available under accession number GSE55349.
2.9. Bioinformatics
Up regulated and down regulated genes were analyzed in the
Kyoto Encyclopedia of Genes and Genomes (KEGG) database
(http://www.genome.jp/kegg/) in order to identify genes with
similar functions. Expression analysis systematic explorer (EASE)
biological theme analysis was conducted online using DAVID
bioinformatics resources server (http//david.abcc.ncifcrf.gov/).
Phylogenetic tree creation (rVISTA), co-expression network
visualization (FunCoup) and in silico miRNA binding sites
prediction (DIANA-mirExTra) are described in Supplementary
methods (Alexeyenko et al., 2011; Alexiou et al., 2010; Dubchak
et al., 2013).
[(Fig._1)TD$FIG]
Fig. 1. Transmission electron microscopy (TEM) images and UV–vis absorption spectra of AuNPs. Morphology and size distributions of citrate-stabilized AuNPs of 5nm (A)
and 30nm (B) in diameter. The histograms show size distributions of given AuNPs size, estimated with ImageJ software. UV–vis absorption spectra (C) of 5nm AuNPs (black
line) and 30nm AuNPs (blue line). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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3. Results
3.1. Characterization of AuNPs
Fig. 1A and B shows representative TEM images of the two nano
gold samples used in this study. The morphologies observed were
mainly spherical, although for 30nm AuNPs it could also be
observed a certain degree of faceting. Size distributions deter-
mined by TEM image analysis were narrow 4.8 1.0 and
32.2 11.0 nm, and the absorption band maximum measured by
UV–vis spectrometry were in agreement with expected diameters
of 5 nm and 30nm AuNPs (Fig. 1C). It has been shown that the
position of the surface plasmon resonance peak of Au NPs can be
used to determine both size and concentration of gold nano-
particles (Haiss et al., 2007). Dynamic light scattering size
measurements were also in agreement with the rest of
characterization techniques (Suppl. Fig. 1) showing a mean size
distribution, expressed as intensity (%), of 7.5 nm and 37.3nm
for 5nm and 30nm AuNPs, respectively.
Disc centrifuge sedimentation analysis using CPS technology
was considered as an appropriate technique to monitor and
measure the size distributions of AuNPs suspension samples in
water, culturemediumwithout serum and in complete cell culture
medium, supplemented with 10% of serum (Table 1). The particles
size distributions inwaterwhenmeasured byCPS are in agreement
with those determined by TEM image analysis. As expected, in the
absence of serum in cell medium, AuNPs aggregated, showing
increase in AuNPs diameters. Aggregation was more noticeable at
higher concentrations and for longer incubation times. However, in
complete cell medium supplemented with serum proteins, no
aggregation was observed and the NPs size was slightly larger to
the one obtained inwater due to the formation of a protein corona.
Zeta-potential measurements (Suppl. Fig. 2) were also per-
formed in order to determine the evolution of the AuNP surface
charge after incubation in cell culture media (with or without
serum) and inwater. Zeta-potential of AuNPs showed initial values
between  30 and  40mV in water. After incubation with cell
culture medium in the presence of serum proteins, for both sizes
(5 and 30nm) and concentrations (100 and 300mM) of AuNPs, a
sudden change of the negative value of zeta-potential already
occurring after mixing (time 0), is observed. At longer incubation
times, zeta-potential values evolved toward the average charge of
serum proteins (zeta-potential about  13.5mV in our experimen-
tal system), which is indicative of the absorption of proteins at the
surface of the NPs.
Finally, the concentration of ions released from the AuNPs
suspensions, when measured by ICP-MS for up to 72h in complete
culture medium, was for both sizes of AuNPs below the detection
limit of the technique (<1ppb).
3.2. Cytotoxicity
Nano gold cytotoxicity in Caco-2 cells was evaluated using two
methods: CFE assay and Trypan blue exclusion assay. The CFE is a
standard test, already optimized for studying the toxicity of NPs
(Ponti et al., 2010) and which is undergoing an inter-laboratory
comparison of performance and reproducibility testing in the
frame of the OECD working party of manufactured nanomaterials
(work in progress). Cells were exposed to 5 and 30nm AuNPs for
24 and 72h, at concentrations ranging from 10 to 300mM, as
described in Supplementary methods.
Statistically significant cytotoxicity was observed only for 5nm
AuNPs when tested by CFE (Fig. 2A and B). Under the same
exposure conditions, small decrease in cell viability at 100 and
300mMwas detected by Trypan blue assay. Although the observed
drop in the membrane integrity was statistically not significant
(Fig. 2C and D), its biological effects as a results of exposure of
Caco-2 cells to 5nm AuNPs, in particular to the highest
concentration tested (300mM), were evident when looking at
detected changes in gene expression patterns. Interestingly, the
cytotoxicity end-points based on changes in the membrane
permeability detected by Trypan blue assay or efficiency in colony
formation observed in CFE, were not statistically significant in
Caco-2 cells exposed to 30nm AuNPs, even for the highest
concentration (300mM) and at the longest (72h) exposure time
tested (Fig. 2). No significant difference in the number of colonies
scored in the negative controls was observed in comparison to the
solvent controls. As expected, for both in vitro cytotoxicity assays,
treatment of Caco-2 cells with 1mM sodium meta chromate
(positive control) resulted in complete cell death (data not shown).
3.3. Nanoparticles internalization
The interaction of 5 and 30nm AuNPs with Caco-2 cells was
studied and quantified by ICP-MS after exposure to 100 and
300mM nano gold suspensions (Fig. 3).
Internalization of gold in Caco-2 cells is expressed as pg/cell of
Au, as % of Au vs total or number of NPs/cell. After 24 and 72h of
exposure at both 100 or 300mM of Au 5nm, cells incorporated
approximately the same amount of Au; while we observed a
dose-dependent increase of the Au 30nm internalisation after
both 24 and 72h of exposure (Fig. 3A).
Interestingly, when the results are expressed as % of Au vs total
exposure, for both AuNPs 5 and 30nm a time-dependent increase
in cell interaction and uptake was observed (Fig. 3B); and when
expressing the data as a number of NPs in each cell the
internalization of AuNPs 5nm seems to be more efficient as
compared to AuNPs 30nm and no dose or time-dependent uptake
manner was observed (Fig. 3C).
Table 1
Mean size distribution of AuNPs as measured by centrifugal sedimentation (CPS). Mean sizes of AuNPs samples (5 and 30nm) incubated inwater, Caco-2 cell culturemedium
without andwith 10% (v/v) serum for 0, 24 and 72h. Incubations took place in a cell culture incubator (in the dark). Abbreviations –HW: half width; PdI: polydispersity index;
nd: not determined.
AuNPs Au conc. (mM) Mean size in water (nm)
HW/Pdl
Mean size in serum free cell medium (nm)
HW/Pdl
Mean size in cell medium with serum (nm)
HW/Pdl
Sampling time 0h 24h 72h 0h 24h 72h 0h 24h 72h
AuNPs 5nm 100 3.9 4.1 4.5 41.0 52.2 47.3 5.5 4.5 4.4
1.4/1.9 1.5/1.8 nd/1.8 21.5/1.2 26.0/1.2 23.7/1.2 nd/5.1 5.2/2.7 5.6/2.6
300 3.9 4.0 4.5 51.1 53.8 50.5 4.9 5.5 5.5
1.7/1.3 1.6/1.3 2.0/1.3 28.3/1.2 27.2/1.2 25.3/1.2 nd/2.6 5.2/1.6 4.9/1.9
AuNPs 30nm 100 22.5 30.4 30.3 56.7 105.1 101.1 23.2 21.8 21.5
6.4/1.3 6.7/1.1 6.4/1.1 26.2/1.3 64.4/1.4 57.8/7.0 6.6/1.4 6.4/1.3 6.3/1.3
300 30.8 30.2 30.7 63.1 109.3 103.1 22.7 22.6 22.5
6.0/1.1 6.3/1.1 5.9/1.1 41.6/1.4 73.7/1.5 81.4/1.6 7.0/1.3 5.9/1.2 5.8/1.4
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3.4. Gene expression profiling
As themajor goal of our work was to get a better understanding
of which molecular pathways might be affected by gold
nanoparticles, we investigated the gene expression profiles of
Caco-2 cells treated for 24 and 72h with 5 and 30nm nano gold, at
two concentrations (100 and 300mM), and compared them with
the RNA transcripts levels of untreated cells (negative control).
First, a comparison of gene expression in cells treated with
solvent (solvent control) vs the negative control was run and
since almost no change was observed in the solvent control of
Caco-2 cells (data not shown), we used untreated cells as reference
control for gene expression profiling experiments. Thereafter, an
induction or repression greater than 1.5 log2 fold change (that
corresponds to an increase/decrease of 50%) and with a false
discovery rate (FDR) corrected p value smaller than 0.05, were used
to compare control data sets vs different treatment conditions
for AuNPs exposures.
At the lower concentration of AuNPs (100mM), a minimal
number of differentially expressed geneswas found. Therewere no
gene transcripts that were regulated by the 5nm AuNPs neither at
24 nor at 72h. However, there were four mRNAs induced in Caco-2
[(Fig._3)TD$FIG]
Fig. 3. Internalization of AuNPs by Caco-2 cells. The AuNPs cell interaction and uptake were measured by ICP-MS in Caco-2 cells incubated in the presence of 5 and 30nm
AuNPs (100 and 300mM) for 24 and 72h. Data are reported as pg Au/cell (A), % of Au in respect to the total Au exposure (B), and number of AuNPs/cell (C).
[(Fig._2)TD$FIG]
Fig. 2. Cytotoxic effects of 5nm and 30nmAuNPs on Caco-2 cells. The cytotoxicity of 5nmAuNPs (black bars) and 30nmAuNPs (gray bars) were estimated by colony forming
efficiency (CFE) and Trypan blue exclusion assays. CFE assay: Caco-2 cells were exposed to increasing concentrations (10–300mM) of AuNPs for 24 (A) and 72h (B). In this
range of concentrations and time points tested, no cytotoxicity was found in Caco-2 cells exposed to 30nmAuNPs; while statistically significant cytotoxicity was observed for
5 nmAuNPs after 24 and 72h of exposure to 200mM(*p<0.05) and 300mM(***p<0.001). Trypan blue exclusion assay: cell viabilitywas tested on Caco-2 cells exposed for 24
(C) and 72h (D) to increasing concentrations of 5 and 30nmAuNPs (50–300mM). Results of both assays represent amean of three independent experiments (three replicates
each) standard error of the mean (SEM) and are expressed in (A) and (B) as CFE (% of solvent control), while in (C) and (D) as viability (% of solvent control), respectively.
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cells exposed to 30nm nano gold (100mM) after 24h, and none of
these genes was further affected after 72h (Fig. 4A). Among these
genes which mRNAs are increased, we find neurotensin receptor 2
(NTSR2) and two zinc finger containing transcriptional factors:
human immunodeficiency virus type I enhancer binding protein 2
(HIVEP2) and zinc finger, DHHC-type containing 11 protein
(ZDHHC11) involved in palmitoylation of proteins (Evers, 2006;
Fukuda et al., 2002; Oku et al., 2013). Moreover, a gene locus
LOC644662, which encodes yet uncharacterized novel long
intergenic non-coding RNA (Zhang et al., 2011) was induced by
30nm AuNPs (100mM, 24h).
At the highest AuNPs concentration tested (300mM), a clear
effect on gene expression can be observed, especially in 5nm
AuNPs treated Caco-2 cells. Here, at the earlier time point (24h),
wewere able to detect 177 regulated genes (all down regulated). At
the later time point (72h) 811 transcripts were differentially
expressed, with 103 up and 708 being down regulated. We
observed a large fraction of genes which were down regulated
already at 24h (163), with their mRNAs levels being also decreased
at 72h (Fig. 4B).
Among the mRNAs highly up regulated upon exposure of
Caco-2 cells to 5nm AuNPs (300mM, 72h), were found the RNA
transcripts of seven members of the methallothionein (MT) family
genes, as well as genes of heme oxigenase (decycling) 1 (HMOX1),
gastrointestinal glutathione peroxidase 2 (GPX2) and glucose-6-
phosphate dehydrogenase (G6PD). Interestingly, already at 24h
time point of 5 nmAuNPs treatment (300mM), the decrease of two
selenoproteins’ mRNAs (SELT and 15kDa selenoprotein) was
detected. A further decrease of SELT and 15kDa selenoprotein
expression levels, as well as mRNAs of two other selenoproteins
(SELK and SEPP1)was observed at 72h after exposure to 5nmnano
gold.
Under the same treatment conditions (300mM) exposure of
Caco-2 cells to larger AuNPs (30nm) had no or very limited effects
on gene expression patterns. For example, after 24h we could not
detect changes in RNA transcripts levels, and only four transcripts
were detected as down regulated 72h after treatment. The RNA
transcripts of the following genes were altered in response to
30nmAuNPs exposure: cadherin 16 (CDH16), carboxypeptidase A2
(CPA2), TSC22 domain family, member 3 protein (TSC22D3) and
cysteine-rich PAK1 inhibitor (CRIPAK). The CDH16 gene product is
a member of the cadherin family of cell adhesion, calcium
dependent, membrane associated glycoproteins. Another mRNA
induced by larger in size nano gold particle tested (30nm), is a gene
product of CPA2, which encodes a secreted protein involved in
catabolic and digestion processes of other proteins (Vendrell et al.,
2000). The third differentially expressed gene TSC22D3 encodes a
leucine zipper transcription factor. Several studies showed that
TSC22D3 gene, also known as GLIZ/DIP/TSC-22R, is induced by
glucocorticoids (GCs), and plays a very important role as mediator
in the anti-inflammatory and immunosuppressive action of GCs
(Ayroldi and Riccardi, 2009). The fourth up regulated gene, CRIPAK
is a novel endogenous inhibitor of p21-activated protein kinase 1
(Pak1). This kinase plays an important role in cytoskeleton
organization, promotion of the cell survival responses and
estrogen receptor (ER) mediated signaling (Talukder et al.,
2006). Among these four genes, the mRNA of TSC22D gene was
also down regulated in response to 5nmAuNPs exposure (300mM,
72h). Thus, the other three genes (CDH16, CPA2, CIRPAK) showed
decrease in their corresponding mRNAs levels only when the
Caco-2 cells were treated with 30nm nano gold particles.
3.5. Validation of microarray data with PCR
A subset of genes identified during microarray profiling was
chosen for validation with real-time quantitative PCR (qPCR). The
target selection of mRNAs (12 targets) for validation study was
based on manual screening of differentially expressed genes, with
[(Fig._4)TD$FIG]
Fig. 4. Differentially expressed genes in Caco-2 cells exposed to 5 and 30nmAuNPs. The bar graph (A) shows numbers of differentially expressed genes across RNA transcripts
present on AgilentWhole HumanGenomeOligoMicroarray (4 44k 60mer slide format) andwhichwere up and down regulated in Caco-2 cells as result of diverse exposure
conditions to AuNPs. The Venn diagram (B) represents shared and time-specific numbers of genes regulated at 24 and 72h after exposure to 5 nm AuNPs (300mM).
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an aim to select mRNAs covering diverse biological and
biochemical functions which might be altered in Caco-2 cells
when exposed to AuNPs.
Several members of genes involved in responses to oxidative
stress, metal exposure and changes in cellular redox status were
chosen for qPCR validation. To this group of validation targets
belong mRNAs of the following genes: oxidative stress induced
growth inhibitor 1 (OSGIN1), HMOX1, MT2A and GPX2 (Gozzelino
et al., 2010; Li et al., 2006; Vašák and Meloni, 2011; Wingler et al.,
1999). As the data from the CFE assay indicated cytotoxic effect of
5 nm AuNPs (300mM, 72h), we included for qPCR validation two
genes encoding regulators of apoptosis: the inhibitor of apoptosis
baculoviral IAP repeat containing 2 (BIRC2) and the apoptosis-
inducing, DNA binding C1D protein (Dubrez-Daloz et al., 2008;
Rothbarth et al., 1999).
We also included gene transcripts of activating transcription
factor 1 (ATF1) and genes involved in post-translational protein
modifications: histone acetyltransferase 1 (HAT1) and ubiquitin-
like modifier SUMO-activating enzyme subunit 2 (UBA2) which is
necessary for the sumoylation of proteins (Hay, 2005; Meyer and
Habener, 1993; Parthun, 2007). Moreover, the set of mRNAs for
validation contains genes encoding DnaJ (Hsp40) homolog,
subfamily C, member 21 (DNAJC21), a chaperone which is
important for protein translation, folding/unfolding, translocation,
and degradation (Qiu et al., 2006); polymerase (DNA directed)
kappa (POLK), with a unique DNA-damage bypass and fidelity
characteristics (Zhang et al., 2000) and serine/arginine-rich
splicing factor 10 (SRSF10) involved in regulation of constitutive
and alternative splicing (Shin et al., 2005).
When selecting mRNAs for validation, we also took into
consideration the trends in gene expression (up regulation and
down regulation) observed in microarray assays, therefore genes
which were up (4) and down (8) regulated were included in the
qPCR validation test (Table 2). As internal reference genes (RGs),
the mRNA transcripts of the c-abl oncogene 1 (ABL1), a
non-receptor tyrosine kinase and a mitochondrial ribosomal
protein L19 (MRPL19) were used. Under given experimental
conditions, these RGs showed to be not affected by exposures of
Caco-2 cells to neither size/concentration/exposure time of
studied AuNPs (data not shown).
Generally, as shown in Table 2, gene expression levels and
trends of regulation (increase/decrease) detectedwithmicroarrays
vs detection and quantification based on qPCR are in agreement
with each other. However, expression levels of mRNAs of HAT1 and
SRSF10 were lower when detecting them with qPCR, indicating
that for these RNA transcripts, the microarray data (300mM, 72h)
over estimated the levels of their down regulation. On the contrary,
for gene BIRC2, HAT1 and MT2A, the qPCR was more sensitive in
detecting the alterations of these particular mRNA expression
levels (100mM, 24 and 72h), where microarrays data was not
indicating their decreased RNA transcripts abundances (Table 2).
3.6. Bioinformatics
After validation of transcriptomics data with qPCR, we
proceeded with a search for significantly enriched gene classes
among differentially expressed genes, as defined by both gene
ontology (GO) annotation and KEGG. This was applied to data sets
obtained from microarray profiling experiments of Caco-2 cells
treated with 5nm AuNPs (300mM) and harvested at 24 and 72h
after exposure.
The genes that were down regulated at 24h time point, showan
enrichment of categories related to transcription co-repressor/co-
factors activities and transcription factor binding, binding of
Table 2
Validation of selectedmRNAs with qPCR. Fold change expresses the difference of the mean log control andmean log stimulated data. Genes identified as regulated (log 2 fold
greater than 1.5 andwith false discovery rate (FDR) corrected [26_TD$DIFF]p value smaller than 0.05) are coloured in red (down regulated) and blue (up regulated). The cells in the table are
coloured in [4_TD$DIFF]gray, when log 2 fold change is greater than 1.5 but the [26_TD$DIFF]p value is not significant.
Gene symbol QPCR Microarray
5 [27_TD$DIFF]nm AuNP
100mM
24h
5nm AuNP
100mM
72h
5nm AuNP
300mM
24h
5nm AuNP
300mM
72h
5nm AuNP
100mM
24h
5nm AuNP
100mM
72h
5nm AuNP
300mM
24h
5nm AuNP
300mM
72h
ATF1  0.21  0.22  0.86  0.86  0.28  0.56  0.87  1.31
BIRC2  0.54  0.64  1.06  1.17  0.32  0.44  0.98  1.10
C1D  0.43  0.46  1.09  1.13  0.46  0.63  0.95  1.28
DNAJC21  0.24 0.09  0.43  0.15  0.18  0.35  0.22  0.63
GPX2  0.20 0.17 0.37 1.19 0.18 0.47 0.31 0.91
HAT1  0.51  0.64  0.55  0.55  0.26  0.49  0.44  0.76
HMOX1 0.00 0.36 0.36 1.82 0.16 0.39 0.29 1.42
MT2A  1.32 0.30 0.48 3.95 0.15 1.94 0.30 3.55
OSGIN1  0.07  0.21 0.32 0.85 0.23 0.29 0.27 0.64
POLK  0.17  0.10  0.82  0.68  0.48  0.26  0.67  0.73
SRSF10  0.17  0.21  0.66  0.52  0.26  0.35  0.61  0.70
UBA2  0.11  0.02  0.59  0.40  0.14  0.18  0.61  0.52
Table 3
GO and KEGG enrichment of altered genes (down regulated) by 5nmAuNPs treatment (300mM, 24h). The p value refers to how significant an association of a particular term
has with the gene list. Where there are more than 10 genes regulated by AuNPs treatment, then only ten most regulated ones are displayed.
Term Count P value Genes
GO:0003714 – transcription corepressor activity 6 0.0035 HSBP1, TBL1XR1, SP100, TAF9B, TFEC, C1D
GO:0008134 – transcription factor binding 10 0.0097 HSBP1, RAB18, TBL1XR1, NPM1, UBA2, SP100, TAF9B, TFEC, TADA1, C1D
GO:0003712 – transcription cofactor activity 8 0.0137 HSBP1, TBL1XR1, NPM1, SP100, TAF9B, TFEC, TADA1, C1D
GO:0000287 – magnesium ion binding 9 0.0139 IMPA1, SAR1B, RFK, POLK, HPRT1, MST4, MMGT1, ACVR1C, DUT
GO:0042802 – identical protein binding 11 0.0014 CLDN12 SP100, AK3, NPM1, ATL2, IMPA1, GCA, HPRT1, SNX6, MST4
GO:0032555 – purine ribonucleotide binding 21 0.0276 ATL2, UBE2W, HSPA13, RAB11A, ARL1, RAB18, ARL5B, RP2, MST4, RFK,
GO:0032553 – ribonucleotide binding 21 0.0276 ATL2, UBE2W, HSPA13, RAB11A, ARL1, RAB18, ARL5B, RP2, MST4, RFK,
GO:0017076 – purine nucleotide binding 21 0.0414 ATL2, UBE2W, HSPA13, RAB11A, ARL1, RAB18, ARL5B, RP2, MST4, RFK,
GO:0005525 – GTP binding 7 0.0464 SAR1B, RAB18, ARL5B, AK3, ARL1, ATL2, RAB11A
KEGG:hsa04120:ubiquitin mediated proteolysis 4 0.0537 UBE2N, BIRC2, UBA2, UBE2W
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magnesium and purine (ribo) nucleotide, and ubiquitin mediated
proteolysis (Table 3; Suppl. Table I). Examples of genes belonging to
these categories include, e.g., HSB1, SP100, TAF9B, MMGT1, POLK,
ATL2, RAB18, UBE2N and UBA2. In the group of genes down
regulated 72h after exposure to 5nm AuNPs, enrichment in
categories related to RNA and Zn ion/transition metal ion binding,
heat shock protein binding, RNA degradation among others were
found (Table 4; Suppl. Table II). These groups of GO/KEGG
categories contain proteins encoded by, e.g., genes of STAU2,
SRP9, RNF219, BIRC2, DNAJB9, DNAJC21, C1D, DCP2.
As shown in Table 5, the up regulated genes at 72h after
exposure of Caco-2 cells to 5nm AuNPs (300mM) turned out to be
significantly enriched in GO biological process classes mainly
related to ion (Cd and Cu) binding, amino acid/amine
transmembrane transporter activity, peptide antigen binding
(several MTs and SLC family members) and KEGG pathways,
represented by GPX2 and G6PD, involved in the glutathione
metabolism. The top highly induced transcripts with 3.55 log2 fold
change (increase in the mRNA levels of about 12 times) belong to
genes encoding metallothioneins (MTs).
In humans, there are at least 18 genes encoding four distinct
isoforms of MTs proteins: MT1, MT2, MT3 and MT4 (Laukens et al.,
2009). The sequence homology grouping of MTs mRNAs is shown
in Suppl. Fig. 3A. For the construction of phylogenetic trees, all
members of the humanMTgene family were plotted and analyzed
against themRNA ofMT2A as a reference sequence. TheMTswhich
mRNAs were induced in Caco-2 cells treated with 5nm AuNPs
(300mM, 72h) are in red, while the MTs which expressionwas not
altered by exposure are in black. The exposure of Caco-2 cells to
5nm AuNPs (300mM, 72h) resulted in up regulation of seven MTs
mRNAs belonging to MT1 and MT2 groups only. Actually, there are
6 mRNAs of MTs (MT2A, MT1l, MT1E, MT1B, MT1X and MT1H)
among 10 top up regulated genes (Suppl. Fig. 3B), with the most
highly up regulated gene being the MT2A. Noteworthy, the
increased mRNA level of MT2A gene detected in the microarray
assay was confirmed with qPCR (Table 2).
When we analysed functions of genes which were among the
highly down regulated (Suppl. Fig. 3C), the gene encoding
selenoprotein T (SELT) was noticed once more. The SELT attracted
our attention because another selenoprotein, namely GPX2 was
highly up regulated (Tables 2 and 5) under the same exposure
conditions (5nm AuNP, 300mM, 72h).
The data analysis for information on mRNA co-expression and
protein-protein interaction of highly up-regulated genes (MT2A,
GPX2 and G6PD) and their connections with oxidative stress
pathway [Hs_Oxidative_Stress_WP408_38774] revealed that
MT2A is connected with 1 gene, while G6PD is connected with
5 genes belong to this biological network (Suppl. Fig. 4A). Notably,
theMT1X gene, connectedwithMT2A, is also up regulated by 5nm
AuNPs (300mM, 72h). When looking at interactomes of most
significantly up regulated and down regulated genes, the following
was found: (i) in the set of genes which were up regulated,
grouping of MTs genes with their mRNA and protein co-regulation
was observed (Suppl. Fig. 4B); (ii) the density of mRNA/protein
co-expression networks of up regulated genes was not as dense as
for genes which were significantly down regulated (Suppl. Fig. 4C)
and showed strong connections between each other.
The observation of a high number of down regulated RNA
transcripts in Caco-2 cells exposed to 5nm AuNPs, in particular at
72h time point (300mM), raised a question: at which level the
repression of genes might have occurred? With the microarrays
data in hand and with the freely available DIANA mirExTra tool for
predicting potential microRNAs (miRNAs) binding targets
sequences in differentially expressed mRNAs, we decided to run
an in silico experiment. In this way, we were able to probe 25 most
significantly down regulated genes, in parallel with 50 not affected
by AuNPs (control genes), for analyzing ad hoc potential epigenetic
regulators of gene expression, at miRNA-mRNA interface levels
(Flynt and Lai, 2008). The results of the prediction test are
presented in Suppl. Table III and in Fig. 5.
We found that, the following miRNAs: miR 340, miR 181a, miR
410 and miR 520d 5p (Fig. 5A), are being frequently identified by
Table 4
GO and KEGG enrichment of altered genes (down regulated) by 5nmAuNPs treatment (300mM, 72h). The p value refers to how significant an association of a particular term
has with the gene list. Where there are more than 10 genes regulated by AuNPs treatment, then only ten most regulated ones are displayed.
Term Count P
value
Genes
GO:0003723 – RNA binding 37 0.0002 ZCRB1, KIN, STAU2, SNRPB2, DCP2, SRSF3, TRUB1, C1D, EIF1AY, SRP9,
GO:0008270 – zinc ion binding 82 0.0048 RNF219, ZNF124, MOBKL3, PTS, ZFAND6, THAP1, BIRC2, RFK, ZFAND1,
PLEKHF2,
GO:0046914 – transition metal ion binding 93 0.0133 RNF219, ZNF124, MOBKL3, PTS, ZFAND6, THAP1, BIRC2, RFK, ZFAND1,
PLEKHF2
GO:0031072 – heat shock protein binding 7 0.0141 DNAJB9, DNAJC10, CDK1, DNAJB14, DNAJC19, GNG10, DNAJB6
GO:0004843 – ubiquitin-specific protease activity 4 0.0225 USP33, USP15, USP1, USP16
GO:0016565 – general transcriptional repressor activity 3 0.0224 SP100, HMGB2, CBX3
GO:0019783 – small conjugating protein-specific protease activity 4 0.0253 USP33, USP15, USP1, USP16
GO:0008353 – RNA polymerase II carboxy-terminal domain kinase
activity
3 0.0394 MNAT1, CDK1, GTF2H2D
KEGG:hsa00563:glycosylphosphatidylinositol(GPI)-anchor biosynthesis 4 0.0189 PIGA, PIGF, PIGY, PIGK
KEGG:hsa03018:RNA degradation 5 0.0413 C1D, DCP2, CNOT7, LSM5, LSM6
KEGG: hsa00740:riboflavin metabolism 3 0.0510 MTMR6, ACP1, RFK
Table 5
The p value refers to how significant an association of a particular term has with the gene list.
Term Count P value Genes
GO:0046870 – cadmium ion binding 4 0.0000026 MT1L, MT1A, MT1B, MT1F
GO:0005507 – copper ion binding 4 0.0009 MT1L, MT1A, MT1B, MT1F
GO:0015171 – amino acid transmembrane transporter activity 3 0.0117 SLC6A6, SLC7A5, SLC43A2
GO:0005275 – amine transmembrane transporter activity 3 0.0182 SLC6A6, SLC7A5, SLC43A2
GO:0042605 – peptide antigen binding 2 0.0341 SLC7A5, CLEC4M
KEGG:Hsa00480:glutathione metabolism 2 0.0999 GPX2, G6PD
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the DIANA mirExTra algorithm and might represent potential
mediators of down regulation of several mRNAs in the analyzed
data set (Fig. 5B). Interestingly, the most down regulated genes
(ZCCHC10, MAD2L1, C13orf27, CNPK, COMMD8) were not among
the best targets for miRNAs mediated post-transcriptional gene
regulation in the given experimental data set prediction context
(Suppl. Table III, Fig. 5B). On the contrary, gene encoding
selenoprotein SELT has 12 predicted binding sites for miRNAs, in
the same number range for predictedmiRNA binding sites (10–17),
as the other down regulated genes have (PLDN, TMEM38B,
ARL6IP6, C14orf129 and GOLT1B). The gene that has the
highest number of predicted miRNAs binding sites (27), encodes
mesoderm induction early response 1, family member 3 protein
(MIER3).
4. Discussion
Several factors are involved in determining cytotoxicity of
engineered nanomaterials (ENMs). Our work focused mainly on
comparing cytotoxic potentials, in the context of inhibitory effect
on colony forming efficiency (CFE)with changes in gene expression
patterns (transcriptomics) induced in Caco-2 cells exposed to 5nm
and 30nm citrate-stabilized AuNPs. Chemico-physical characteri-
zation tests of AuNPs used in this study confirmed that AuNPswere
of expected size/shape and behaved in the experimental media as
previously reported by Coradeghini et al. (2013).
In this workwe selected undifferentiated Caco-2 cells an in vitro
model of the intestinal route of exposure to nanoparticles. When
Caco-2 cells are cultured over confluence for 21 days, these cells
undergo spontaneous cell cycle arrest and differentiation. In his
process, the enterocyte-like monolayer is formed serving as a
model of the intestinal barrier (Sambuy et al., 2005; Natoli et al.,
2012). Due to the intrinsic heterogeneity of the original parental
cell line and culture-related conditions upon differentiation the
expression of morphological and functional characteristics of
mature enterocytes varies greatly between experiments and
laboratories. Taking this into consideration, we have chosen to
use in our work undifferentiated Caco-2 cultures to study their
biological responses to AuNPs exposure. In this way we looked at
populations of heterogenic pool of Caco-2 cells prior to differenti-
ation, therefore having wider plasticity in the cellular physiology,
sensing and adaptation/response to stress, as compared to mature
and polarized enterocytes (Tadiali et al., 2002). Keeping this in
mind, when running both the cytotoxicity and RNA transcript
profiling experiments, we explored Caco-2 cells (in undifferenti-
ated stage) as potentially more suitable model for detecting
alterations in gene expression patterns upon exposure to NPs. We
have to stress, that in that particular case, undifferentiated
Caco-2 cells might have shown culture growth condition specific
routes and efficiency in uptake of NPs. This in turnmay contributed
in part to alternative cellular responses to stress and gene
expression patterns, as compared with possibly different
responses of classical model of mature enterocyte-like Caco-
2 monolayer cells (Tremblay et al., 2006; Natoli et al., 2011).
When exposed to AuNPs, Caco-2 cells efficiently uptake AuNPs
at both incubation times tested (24 and 72h). However, we did not
detect further increase in cellular uptake at later time point (72h),
maybe due to reaching of a steady-state of the uptake. These
findings are in line with data reported earlier, supporting the
notion that extending the incubation times above 24h might not
be useful for enhancing cellular uptake of nanoparticles, as
observed in primary HUVECs, C17.2 neural progenitor cells and
rat PC12 cells (Soenen et al., 2012), but in contrast with results
obtained with mouse Balb/3T3 cells (Coradeghini et al., 2013). In
the later case, time dependent increase in uptake of AuNPs, even
after 24h exposure time, was observed.We have also observed that
if we express the uptake in number of NPs/cell or % of AuNPs versus
total exposure, at the same external dose of exposure, the 5nm
AuNPs cell internalisation is higher than 30nm AuNPs. This result
is probably due to the fact that cells are exposed to a number of
small NPs that is approximately 100 times higher than bigger NPs.
In addition, as previously observed for Balb/3T3 cells (Coradeghini
et al., 2013) by TEM analysis, both 5 and 30nmNPs are internalised
by endocytic patway.
When testing cytotoxic effects of AuNPs at the cellular level, we
observed inhibition of Caco-2 cell growth and decrease in colony
forming efficiency, induced by smaller AuNPs (5nm). We must
admit that this cytotoxic effect was observed only at relatively high
levels of exposure (200mM and 300mM), with the most evident
inhibitory effect detected at concentration 300mM at 72h. At the
molecular level, when measuring biomarkers related to AuNPs
exposures by changes in RNA expression levels, broad range of
responses which potentially mediate inhibition of cellular growth
and other functions of Caco-2 cells in response to nano gold, were
identified. These cellular processes affected by exposure to 5nm
AuNPs include, for the early time point examined (24h), down
regulation of genes involved in regulation of transcription
(transcriptional factors), biogenesis of RNA and GTP binding
among others. At the later time point studied (72h), more dramatic
changes in differentially expressed gene expression patterns
evoked by 5nm AuNPs were detected. Beside 708 down regulated
genes, an increase in abundance of 103 RNA transcripts was also
observed. Thus, our gene expression profiling experiments
demonstrated that RNA/zinc ion/transition metal ion binding,
heat shock protein binding, RNA degradation and splicing
(decreased); cadmium/copper ion binding, amino acid/amine
transmembrane transporter activity and glutathione metabolism
(increased),were among the cellular response processes correlated
with exposure of Caco-2 cells and were associated with
cytotoxicity induced by smaller AuNPs (5nm, 300mM).
[(Fig._5)TD$FIG]
Fig. 5. Predicted miRs with the corresponding target genes that were decreased upon exposure of Caco-2 cells to 5nm AuNPs (300mM, 72h). Group of miRs having 5–9
predicted target mRNAs (A). Set of genes with the highest number of predicted miRs binding sites in their mRNAs sequences (B). In gray are indicated mRNAs with no miRs
binding site prediction. Asterics (*) denotes the most down regulated genes. Both word clouds were generated using the data presented in Suppl. Table 3.
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Interestingly, although the larger (30nm) AuNPs had rather
limited effect on Caco-2 cell mRNAs expression, these AuNPs were
still able to induce expression of couple of genes already at 100mM
exposure level at 24h time point (CDH16, CPA2, TSC22D3 and
CRIPAK). Noteworthy, the CDH16 protein was shown to be
exclusively expressed in the kidney (Thomson et al., 1995);
however its mRNA transcript induction was evident when the
Caco-2 cells, originating from the colon, were exposed to 30nm
AuNPs.
As mentioned earlier, treatment of cells with 5nm AuNPs had
very pronounced effect on increase in mRNAs levels of
metallothioneins (MTs) genes belonging to the MT1 and MT2
isoforms only. Exposure to nano gold had no effect on the MT3 or
MT4 mRNAs expression in Caco-2 cells (gastrointestinal origin)
due to the fact that MT3 is usually expressed in neurons (Masters
et al., 1994), while MT4 is exclusively found in stratified squamous
epithelium (Quaife et al., 1994).
Differential expression of selenoproteins (GPX2" while SELT,
SEPP1, SELK and 15kDa selenoprotein#), might be related to
changes in levels of selenium. Selenoproteins belong to a group of
proteins which play important role in, e.g., oxidative stress
signaling and protection, redox homeostasis, thyroid hormone
metabolism, protection of some forms of cancer among others
(Papp et al., 2010). It has been shown that the mRNA stability of
selenoproteins differs depending on the availability of selenium
within the cell (Schomburg and Schweizer, 2009). Therefore, we
have hypothesized that Caco-2 cells might have responded to high
concentration of AuNPs as if they have faced selenium “deficiency”.
It is also possible that high concentration of gold within the
cell or/and extra cellular milieu had an effect on selenium
homeostasis or/and its availability for uptake by Caco-2 cells.
Lowered cellular selenium content can evoke Nrf2 and Wnt
stress response signaling via disturbed redox state as demonstrat-
ed by Brigelius-Flohé and Kipp (2013). The changes we found in
expression of genes belonging to Nrf2mediated signaling cascades
(metallothioneins, HMOX, OSGIN1, G6PD, GPX2 and other sele-
noproteins) are indeed well described targets of regulation by
transcriptional factor Nrf2 (Kensler et al., 2007; Miles et al., 2000).
Therefore, changes in expression of genes being under Nrf2 control
and induced by small AuNPs (5 nm)might be the result of different
triggers: metal exposure, oxidative stress, disturbed redox and
selenium status, and/or combination of them. Noteworthy, it was
recently observed that Nrf2 is activated in Caco-2 cells upon
exposure to high concentrations of silver NPs (Aueviriyavit et al.,
2014) supporting our reasoning that induction of mRNA levels of
the genes mentioned above, involves Nrf2 mediated signaling
events, at least to some extent.
The results presented here clearly indicate that the cancer cells
used in this study were able to recognize the AuNPs not only as
metal entities but also as potential “danger” signals and stress
inducers. Although Caco-2 cells showed the capacity to activate
Nrf2-mediated defense networks (Kensler et al., 2007), these
responses were not sufficient in preventing toxic effect of 5 nm
AuNPs that were observed in CFE assay. Consequently, stress
resulting from cytotoxic level of smaller AuNPs had an effect on
down regulation of genes important for RNA biogenesis
(transcription, splicing) and post-translational modifications
(ubiquitination, sumoylation) of proteins that are vital for protein
stability, activity and turn-over (proteolysis), especially when the
misfolding of proteins occurs, for example during oxidative stress.
Therefore, Caco-2 cells exhibited slower growth and lower
efficiency in forming colonies.
It is well known that gene expression can be regulated at
chromatin level (histone code) and RNA level (transcription,
splicing, post-transcriptional RNA modifications, RNA stability/
turn over of RNA transcripts, cellular localization of RNAmolecules,
their translation etc.). These processes quite often involve and are
regulated by non-coding RNAs (ncRNAs), including small (20–22 nt
long) non-coding microRNAs (Venkatesh et al., 2013; Ullah et al.,
2014). For that reason, we tested in silico the microarrays
expression data for the presence of miRNAs binding sites across
highly down regulated mRNAs (300mM, 72h, 5 nm AuNP). Indeed,
prediction analysis pointed out that some miRNAs (miR 340, miR
181a, miR 410, miR 520 d5p) could play to some extend a role in
down regulating many of tested mRNA targets.
The explanation of the very weak response of Caco-2 cells at
transcriptome level, upon exposure to larger AuNPs (30 nm),
remains still unclear. When interpreting our results the following
explanation(s) can be suggested. As already reported in literature,
the cellular uptake of engineered nanoparticles depends on the
size of nanoparticles (Wang et al., 2010; Labens et al., 2013; Li and
Schneider, 2014). In our experimental settings, the number of
AuNPs taken up by the cells is much higher in the case of smaller
NPs (5 nm), and this by itself might represent more biologically
significant “stimulus”. Thereafter, combination of the frequency
of cellular membrane association/engulfment, uptake and exocy-
tosis of 5 nm AuNPs, may trigger much stronger effect on
signaling events, as compared to 30 nm AuNPs that are present
in lower number but at the same molar Au concentration
(Bahrami et al., 2014; Oh and Park, 2014). Moreover, it is also
possible that smaller AuNPs (5 nm), with higher surface area to
volume ratio, resulting in higher reactivity toward biological
molecules (Nel et al., 2009), are more “disruptive” to the
homeostasis of exposed cells as compared to larger AuNPs
(30nm). The different expression profiles observed in Caco-2 cells
exposed to the two different sizes of nano gold particles, gave
an additional support to previously published findings
demonstrating that isotropic AuNPs larger than 5nm seem to
be biologically inert (Li et al., 2014).
We must stress however, that although the larger AuNPs
showed very limited activity at transcriptional level, the picture of
cellular responses might be different when looking at different
exposure time (e.g., earlier sampling time), end-points/markers
(protein expression, post-translational modifications, cellular
metabolism, intracellular trafficking/secretion of bio-molecules,
etc.). Also, the fact that Caco-2 cells were exposed to much higher
number of small AuNPs as compared to larger AuNPs, points out
that some cytotoxic effects might be observed even for 30nm
AuNPs, if given to cells in adequately higher numbers.
Interestingly, Caco-2 cells actually responded to 30nm AuNPs
already at 24h by up regulating four gene transcripts after being
exposed to this AuNPs (100mM). Notably, under the same exposure
conditions, presence of 5nm AuNPs in the cell culture medium
and/or as adsorbed/internalized AuNPs by cells, did not affect gene
expression patterns in Caco-2 cells. One possible explanation is
that the mass transfer of larger AuNPs (30nm) to the cellular
surface and interactionwith cellularmembrane, as a result ofmore
rapid gravitational settling/sedimentation (Wittmaack, 2011;
Li and Schneider, 2014) which is higher as compared to smaller
AuNPs, triggering diverse signaling events, at different time points
andwith possible different effects on gene expression as compared
to these evoked by exposure to 5nm AuNPs.
The observed cytotoxic properties of smaller AuNPs might be of
practical use for enhancement of already existing AuNPs based
thermal therapies, as well as in other cancer treatment regimes
(Schütz et al., 2013). Nevertheless, we should not ignore the fact
that changes in gene expression induced by 5nm AuNPs exposure
might lead to potentially hazardous effect for healthy cells and/or
tissues that still need to be estimated and characterized despite the
absence of acute toxicity effects. This is of great concern, especially
for individuals who are undergoing long-term AuNPs-based
treatment.
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5. Conclusions
A combination of standard cytotoxicity methods, such as CFE
and Trypan blue exclusion assays, with gene expression profiling
(transcriptomics) allowed us to identify cellular signaling and
stress response pathways that might be associated with the
cytotoxicity observed upon exposure of Caco-2 cells to citrate-
stabilized AuNPs (5nm). However, it is critical to point out that
changes in gene expression at mRNA level do not necessarily
correlate with observed trends (up/down regulation) in the
amount of corresponding protein (Walker and Hughes, 2008).
Therefore, validation(s) of alterations in mRNA expression,
observed in Caco-2 cells as response to AuNPs exposures, requires
further work to estimate the changes in the corresponding
expression of encoded protein(s), their activity, proper localization
and/or secretion. The very same approach also applies for testing
whatever the predicted involvement of miRNAs and/or other
ncRNAs takes place and might contribute to cellular responses
evoked by treatment of Caco-2 cells with AuNPs.
Nevertheless, data presented here provide a starting point in
exploration of possible mechanisms related to cytotoxicity
observed in cells exposed to AuNPs and can be applied for
designing more efficient and safe nano gold nanomedicines.
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High variability of genomic 
instability and gene expression 
????????????????????????????????
Annalisa Frattini1,2, Marco Fabbri2, Roberto Valli2, Elena De Paoli2, Giuseppe Montalbano2, 
??????????????3, Francesco Pasquali2 & Emanuela Maserati2
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to a hypoxic stimulus. Our study emphasizes the large genomic and transcriptomic variability among 
??????????????????????????????????????????????????? ?????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????? ??????????????????????????????????????
???????????????????????????????????????????????????? ????????????????????????????????????????????
Since HeLa was rst established as a human cancer cell line in 19521, it has become probably the 
most-used human cell line in biological research. e cell line was established from the invasive cer-
vical adenocarcinoma of a young patient, Henrietta Lacks, who eventually died in 1951, and it was the 
rst successful attempt to establish a culture of immortalized human cells. Starting with the pioneering 
research of Jonas Salk, who developed the rst polio vaccine2, the use of HeLa cells has contributed to 
many fundamental scientic breakthroughs.
HeLa cells have been employed to investigate cancer, AIDS mechanisms3, and the eects of drugs4, 
toxins5 and radiation6. ese cells have also been used in the Nobel-winning experiments that led to the 
discovery of telomeric activity7,8.
Furthermore, to verify the gene-editing eects involved in specic cellular processes, gene expression 
proles and proteome analyses have been applied to HeLa cells9–11. e widespread use of this cell line is 
mainly due to the ease with which they can be handled and manipulated in dierent conditions.
Starting from the 1950 s, approximately 80,000 studies have reported results obtained using the HeLa 
cell line as a physiological model. In the majority of these studies, the source of the HeLa cell line is not 
specied, implying a lab-to-lab origin (Supplementary Table S1).
Several published studies reported that HeLa cells are characterized by extensive chromosome insta-
bility (CIN)12–19 (Supplementary Table S1), although one study concluded that they are stable and able 
to maintain a constant number of chromosomes mitosis aer mitosis20.
A few years aer the establishment of the line, one of the rst studies on the metaphase spreads of 
clonal cell strains of HeLa was published in 195821, showed a relatively narrow chromosome number dis-
tribution between 75 and 82. e large number of duplications and deletions compared with the normal 
human genome has already been extensively described19 (Supplementary Table S1), and as chromosomes 
provide genome identity, it might even be argued that the HeLa genome is no longer a human one22. In 
1991, it was even proposed that the HeLa cell could be considered a new species (Helacyton gartleri)23.
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To our knowledge, all of the reports regarding HeLa CIN have been conducted on a single cell clone 
or on sub-clones20,24. Recently, the HeLa genome and transcriptome was exhaustively characterized by 
deep RNA and DNA sequencing performed on a single clone from CLS Cell Lines Service GmbH (the 
HeLa Kyoto cell line)25. To investigate the reported instability of the HeLa cell lines and to verify the 
possibility that erroneous conclusions could be generated by the use of HeLa cells obtained from dierent 
laboratories, we compared dierent “batches” obtained from four Italian laboratories (HeLaSR, HeLaV, 
HeLaP, and HeLaH). HeLaP and HeLaH were derived from the same batch but had been cultured in 
two dierent laboratories for approximately 8 years; similarly, HeLaV was derived from the same batch 
as HeLaSR but had been cultured in two dierent laboratories for approximately 12 years.
Results
???????????????????????????????????????? ????????????? We evaluated the genomic stability of 
these “batches” by karyotyping, array-comparative genomic hybridization (a-CGH) and uorescent in 
situ hybridization (FISH described in the next section).
Cytogenetic analysis was performed on 20 metaphase spreads stained using the quinacrine-based 
Q-banding technique (QFQ). "e HeLa cells were near-triploid, containing a range of 60–66 chromo-
somes in HeLaSR, 56–79 in HeLaV, 71–79 in HeLaP, and 63–79 in HeLaH. In addition, approximately 
10% of the metaphase spreads of clone HeLaSR exhibited chromosome numbers ranging from 101 to 
148, whereas HeLaV (derived from the HeLaSR batch) exhibited a range of 124–198 chromosomes in 
approximately 30% of its metaphase spreads. We excluded the coexistence of two dierent sub-clones by 
monoclonal sub-culturing.
Ten HeLaV clones, derived from a monoclonal sub-culture, showed the presence of both metaphase 
populations (with a range of 49–81 and a range of 92–240 chromosomes), suggesting that a single cell 
could carry the inherent defect, possibly generated by new mutation events. For our FISH and tran-
scriptomic analysis, we used the batch HeLaSR because it showed fewer mitoses with double the modal 
chromosome number compared to HeLaV.
To characterize all of the genomic imbalances of the four “batches”, we performed a-CGH. As showed 
in the Circos plot26 (Fig.  1A), a comparison between the HeLa DNA content and the diploid human 
genome evinced a substantial dierence among the four lines analysed. "e comparison of the 4 HeLa 
clones underscored that although the amount of gain and loss of genomic material compared to the 
human diploid genome is highly variant among the 4 clones, there is similarity within the pairs with a 
common origin, i.e., HeLaH/HeLaP vs HeLaSR/HeLaV (Fig. 1B).
To express the similarities among the HeLa clones, we calculated the percentage of the genomes with 
the same annotation (diploid, deleted or ampli$ed). "e results, depicted in Fig. 1C, show high similar-
ity within the two pairs HeLaSR/HeLaV and HeLaH/HeLaP. We emphasize that even recently split-out 
batches (HeLaSR vs HeLaV and HeLaH vs HeLaP) present speci$c gains or losses and that these new 
events are acquired and stably maintained. A possible hypothesis to explain the dierent chromosome 
imbalances between the two pairs could be ancestral mutational events that conferred an evolutionary 
advantage in DNA losses or gains.
?????????????????????????????????????????????? To identify chromosomal rearrangements and to 
verify the presence of HeLa-speci$c markers observed by karyotyping17,20, we performed a FISH analysis 
to paint chromosomes 1, 3, 5, 9, 13 and 19 in HeLaSR and HeLaP because they appeared to be the two 
most dierent clones by a-CGH. As shown in Table  1, HeLaP displays almost all of the HeLa-speci$c 
markers previously identi$ed12,20,25, whereas HeLaSR has lost most of them. In addition, we found in 
each clone the presence of new speci$c markers (Supplementary Fig. S1), con$rming an independent 
evolution of each batches.
??????????????? ????????? ???????? ?????????????????????? ???????? ??????????? ??? ?????????????
??????????? ??? ????? ???????????? Our genomic analysis uncovered deep variability between the-
batches , and because genomic gains or losses or whole-chromosome aneuploidy can have drastic conse-
quences on gene expression27, we performed a whole-transcriptome analysis to verify the transcriptional 
eects of this dierential chromosome instability. "e microarray expression analysis was performed 
on HeLaSR and HeLaP, the batches most dierent in terms of genomic content. "ese cell lines were 
exposed to hypoxic conditions, chosen because the induced hypoxic pathway is well characterized28,29.
A principal-component analysis (PCA) was performed to determine the expression trends within the 
dataset. PCA is a useful technique to reduce the dimensionality of large data sets and to visually assess 
similarities and dierences between samples30. PCA was used to identify trends in the regulation of genes 
induced by hypoxic exposure and to map the entire dataset on a two-axis graph (principal components, 
PC1 and PC2) where the distances account for similarity (Fig.  2A); the closer the distance between 
samples, the more they are similar. "e main divergence was due to two dierent clones, HeLaSR vs 
HeLaP (triangles and circles, respectively), as demonstrated by the $rst principal component (PC1). "e 
second component (PC2), summarizing the eects of hypoxia, highlighted strong changes in HeLaSR 
and mild changes in HeLaP. Indeed, untreated HeLaP and HeLaP a&er hypoxia are closer to each other 
than untreated HeLaSR is to HeLaSR a&er hypoxia, meaning that hypoxia has a stronger eect in HeLaSR 
than in HeLaP (Fig. 2A). Furthermore, we identi$ed the genes regulated by hypoxic treatment in these 
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Figure 1. !e genomic landscape of the 4 HeLa cell lines. (a) Circos plot of the four HeLa genomes 
compared with the diploid human genome, with tracks representing the gain (green) and loss (red) of 
genomic material. (b) e histogram summarizes the percentage of the gain (green) and loss (red) of 
genomic material in the 4 cell lines compared to the diploid human genome, highlighting the separate 
evolution of the two pairs of HeLa clones (HeLaH and HeLP vs HeLaSR and HeLaV). (c) e histogram 
shows the percentage of similarity in genomic content in each HeLa clone compared with the other lines 
and emphasizes that the two more similar lines, based on their common origin (HeLaH and HeLaP; HeLaSR 
and HeLaV), bear dierences in their genomic content.
www.nature.com/scientificreports/
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two clones: 2,900 (1,666 genes upregulated and 1,234 downregulated) genes were mis-regulated only in 
HeLaSR, whereas 145 genes were mis-regulated only in HeLaP (104 up and 41 down). A total of 89 genes 
(88 up and 1 down) were mis-regulated in both cell lines (Fig. 2B).
ese three gene lists were analysed for gene ontology (GO) enrichment (Fig. 2C). e more signif-
icant GO classes those that are dierentially expressed between HeLaSR and HeLaP, demonstrating the 
large dierences in the expression proles of the two cell lines in response to hypoxia.
e classes related to hypoxia were present in both, but they were not the most signicant (Fig. 2C). 
On the contrary, when we analysed the 89 mis-regulated genes common to both cell lines, the most 
enriched classes are related to hypoxia (Fig. 2B,C). ese results suggest that the dierent genomic con-
tents of the two clones have a remarkable inuence on basal gene expression and, consequently, on the 
response to a hypoxic stimulus. e cells activate dierent pathways, but interestingly, the regulation of 
hypoxia-related genes is preserved.
??????? ?????????????????????? ???????????????? A subset of regulated genes identied for their 
relevance in the hypoxic response were validated by real-time RT-PCR (qPCR) (Supplementary Table 
S2). e trend of the array data was conrmed by qRT-PCR (Supplementary Table S3).
????????????????????????????????????????????????? Because signicant chromosome copy num-
ber alterations are frequently associated with gene expression changes in the aected regions31, we evalu-
ated the possible eects of copy number variation on gene expression32 in our samples. Based on the data 
obtained with a-CGH and the expression array performed on HeLaP and HeLaSR samples as previously 
described, a general lack of dosage compensation was observed in HeLaP (Fig.  3A) and in HeLaSR 
(Fig. 3B), meaning that gene dosage is correlated to gene expression.
Discussion
Genetic aberrations, such as gene amplication, deletions, and loss of heterozygosity, are hallmarks of 
cancer and are major contributors to the neoplastic process through the accumulation of mutations in 
Chromosome markers previously 
reported17–20 HeLaSR HeLaP
M1 der(1)t(1;3)(q11;q11) 10/10 9/10
M2 der(1;9)(p11;q11) 0/10 4/10
M4 der(3;5)(p11;q11) 10/10 0/10
M5 der(3;20)(q10;q?10) 8/10 8/10
M7 i(5)(p10) 10/10 10/10
M8 der(7)t(7;19)(q35;?) 0/10 9/10
M10 der(9)t(3;9)(p21;p11) 0/10 8/10
M11 der(11)t(9;11;9)
(?;p14?q33?;?dup(11)(p?)dup(11)(q?)
0/10 10/10
M14 der(19)t(13;19)(q21;p13) 10/10 10/10
M22 der (5;9)(p10;p10) 0/10 10/10
Loss or acquired chromosomes
 + chr.1 9/10 5/10
 − chr. 3 10/10 10/10
 − 2 chrs. 5 0/10 10/10
 + chr.9 2/10 1/10
 − chr. 9 0/10 3/10
 − chr. 13 10/10 1/10
 − chr. 19 2/10 10/10
Specic new markers
 i(1p) 1/10 0/10
 i(5q) 0/10 10/10
 t(3p;13q) 10/10 1/10
 t(6;19) 10/10 1/10
Table 1.  HeLa cell line’s speci!c markers of HeLaSR and HeLaP lines. Marker identication by FISH 
using WCP (Whole Chromosome Painting) for chr.1 vs chr. 3; chr. 5 vs chr. 9; chr.13 vs chr.19 (see 
Supplementary Fig. S1). Ten metaphases for each HeLa clone were analysed.
www.nature.com/scientificreports/
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specic genes. e mechanisms through which these mutations are generated are the subject of contin-
ued debate33–37, and several cancer-predisposing mutations aect genes that are responsible for maintain-
ing the integrity and number of chromosomes during cell division.
e main factors that control chromosome stability are telomere maintenance, cell division mecha-
nisms, and the mitotic checkpoint that ensures correct chromosome segregation38–40.
Consequently, the archetypical transformation of tumour cells results in CIN41,42. Established cell lines 
have been traditionally used to characterize the biological signicance of specic genomic aberrations 
identied in primary tumours43 and to test the therapeutic ecacy of anticancer agents44.
HeLa was the rst cultured cancer line45. Although its CIN has already been extensively investigated19 
(see Supplementary Table S1), demonstrating the low degree of similarity with the initial tumour and 
Figure 2. Transcriptional landscape. (a) Principal component analysis (PCA) of the transcriptome. e 
PCA maps the entire dataset on a two-axis graph (principal components, PC1 and PC2), where the distances 
account for similarity. Untreated HeLaP cells (white circles) and HeLaP cells a!er hypoxia (black circles) 
are closer to each other than untreated HeLaSR cells (white triangles) are to hypoxic HeLaSR cells (black 
triangles), suggesting that hypoxia exerts a stronger eect on HeLaSR cells than on HeLaP cells. (b) Venn 
diagram showing the number of genes either upregulated or downregulated due to hypoxia in the HeLaP 
and HeLaSR clones compared to their respective controls. (c) Gene ontology of genes either upregulated or 
downregulated by hypoxia in HeLaSR and HeLaP cells.
www.nature.com/scientificreports/
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with the human diploid genome, this cell line is largely used in biomedical research. e HeLa cell line 
is among the most frequently utilized models in research to validate drugs for cancer therapy46 and for 
genetic/epigenetic manipulation using demethylation agents47, siRNA and expression vectors to study 
gene function48–50.
Here, we report the high level of CIN in HeLa clones obtained from dierent laboratories. We demon-
strated that each clone accumulates genomic variability in a time-dependent manner. We speculate that 
some chromosomal rearrangements or point mutations that randomly arose in each clone increased 
survival, leading to a kind of “genetic dri” in clonal variants.
is conclusion is evident in the diering DNA content of the clones HeLaSR and HeLaV, which 
showed a loss of genomic DNA, whereas HeLaH and HeLaP exhibited a gain of genomic DNA in com-
parison with the diploid human genome. We speculate that even slightly dierent culture conditions may 
produce this divergence. e number of passages that a cell line undergoes can certainly lead to exten-
sive modications in growth rate, morphology, aneuploidy, chromosome alterations, gene expression 
and drug sensitivity, depending on the culture environment51–55. In addition, we demonstrated that the 
genomic gains or losses or whole-chromosome aneuploidy is specic to each analysed clone (Fig.  1A) 
and that these dierences in genomic content have a remarkable inuence on basal gene expression 
(Fig. 2A). We showed that in response to a hypoxic stimulus, each cell line activates dierent pathways, 
although the regulation of genes related to hypoxia is conserved (Fig. 2A,C).
ese results suggest that dierent HeLa batches used for the same experiment may yield dierent 
results. e large dierences in the basal gene expression proles suggest that the use of uncharacterized 
clones may lead to faulty conclusions and to irreproducible results in studies of gene function and path-
way analysis. With respect to genomic content, the use of uncharacterized batches of HeLa cells56 may 
result in dierent behaviours between clones in response to specic stimuli, such as cancer drugs, used 
in biomedical research.
Our results suggest that not a single HeLa cell line, or even a set of similar HeLa cell lines, exists. 
Rather, an indeterminate number of clones exist, each carrying large genomic dierences that lead to 
dierent expression proles. e HeLa cell recalls the main character of the novel by Pirandello (the 
Italian poet awarded the 1934 Nobel Prize in Literature): “One, no one, one hundred thousand”57: the 
HeLa cell line is thought to be a unique cell line (“one”), but it is clear that large dierences exist between 
the tumour from which it was derived and the human genome (“no one”) and that an indeterminate 
number of HeLa cell lines are scattered in laboratories worldwide (“one hundred thousand” or more), 
each with a unique genomic prole.
Methods
???????????? e cell lines HeLaP, HeLaH, HeLaSR and HeLaV were obtained from four Italian labora-
tories. HeLaP and HeLaH were derived from the same cell-line batch but were cultured in two dier-
ent laboratories for approximately 8 years. Similarly, HeLaSR and HeLaV were derived from the same 
cell-line batch but were cultured in two dierent laboratories for approximately 12 years. In our lab, 
the mycoplasma-free cell lines were cultured in DMEM-F12 (Euroclone SpA, Milan, Italy) with 10% 
heat-inactivated foetal bovine serum (Euroclone), 1 mM glutamine, 100 U/ml penicillin and 100 µ g/ml 
streptomycin and were incubated at 37 °C and 5% CO2. e cells were cultured to reach a conuence of 
80–90%.
???????????? ?????????? Metaphase spreads were obtained from the four cell lines. Aer culturing, 
the cells were treated with 0.04 µ g/ml colcemid for 2 hours. e cells were harvested by treatment with 
a 1× trypsin/EDTA solution for approximately 5 min. A hypotonic treatment was performed with 0.96% 
Na citrate for 15 min at 37 °C, and the cells were subsequently xed in a fresh methanol/acetic acid 
Figure 3. Gene expression by copy number in HeLaP and HeLaSR cells. Transcript abundance (arbitrary 
unit) is positively correlated with gene copy number. (a) HeLaP gene expression in untreated (white) and 
hypoxic (grey) cells. (b) HeLaSR gene expression in untreated (white) and hypoxic (grey) cells. A general 
lack of dosage compensation was observed in both cell lines.
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(3/1, v/v) solution. Metaphase spreads were stained overnight with 0.005% quinacrine mustard solution 
in McIlvaine buer (QFQ-banding), and standard cytogenetic analyses were performed with a Leica 
D5000B uorescent microscope.
Monoclonal subculturing by limiting dilution. To exclude the possibility that the HeLaV and 
HeLaSR cell lines arose from 2 dierent HeLa subclones, we obtained a cell culture derived from a 
single cell by limiting-dilution culture. We prepared serial dilutions to obtain a suspension containing 
1 cell/µ l. A single µ l of the !nal cell suspension was seeded into each well of a 96-well plate containing 
growth medium. "e presence of a single cell was evaluated by microscopy, and the cells were incubated 
at 37 °C and 5% CO2 overnight. A$er one day, we used microscopy to con!rm the presence of a single 
cluster of cells (2 or more) per well, implying a single-cell origin, and we excluded any wells with double 
or multiple clusters of cells. "e monoclonal cell lines were trypsinised and seeded in T25 asks to obtain 
su&cient cells for the metaphase spread analysis.
Fluorescence in situ hybridization experiments. Metaphase spreads were hybridized with Cytocell 
Aquarius Whole Chromosome Painting probes (WCP Probes) using the codenaturation protocol. Briey, 
20 µ l of ready-to-use probes were deposited on the slide and sealed with a coverslip using rubber cement. 
Codenaturation was performed on a HyChrome hybridization machine at 75 °C for 2 min, and hybridiza-
tion was conducted overnight. "e slides were then washed for 2 min in 0.4× SSC buer at 72 °C and for 
30 min in 2× SSC/0.05% Tween 20 at room temperature. Metaphases spreads were then counterstained in 
2× SSC buer with 200 ng/ml of 4,6-diamidino-2-phenylindole (DAPI) and then mounted with an anti-
fade solution (Vector Laboratories INC., Burlingame, CA, USA). "e samples were analysed with a Leica 
DM5000B uorescence microscope, and images were captured with the Leica QFISH so$ware system.
DNA extraction. DNA was extracted from approximately 10 × 107 cells using the DNeasy Blood and 
Tissue kit (Qiagen S.r.l. Milan, Italy) according to the manufacturer’s protocol. Genomic DNA was quan-
ti!ed using an ND-1000 UV-Vis spectrophotometer ("ermo Scienti!c, Wilmington, DE, USA).
?????? ?????????? a-CGH was performed on an Agilent microarray platform (Agilent Technologies 
Inc., Santa Clara, CA USA) with an Agilent’s human 4 × 180 K CGH slide. Sample preparation, label-
ling, and microarray hybridization were performed according to the Agilent CGH Enzymatic Protocol 
version 7.3. Slides were scanned using the Agilent G2565CA scanner and analysed using the Agilent 
Feature Extraction 10.7.3.1 so$ware. "e a-CGH pro!le was extrapolated using the Agilent Genomic 
Workbench 6.5.0.18 so$ware with the following parameters: ADM-2 threshold 6, Fuzzy Zero ON, and 
Centralization OFF. Coverage plots were generated using the Circos visualization tool compared with the 
2.2 × 109 genome covered by the Agilent probes.
Hypoxic treatment. Before administering the hypoxia treatment, the HeLaP and HeLaSR cells were 
maintained at 70–80% conuence. "e medium was refreshed before the hypoxia treatment. Cells (two 
asks per cell line) were maintained under hypoxic (1% O2, 5% CO2, 94% N2) conditions or normoxic 
(95% air and 5% CO2) conditions for 24 h.
RNA extraction. Total RNA was puri!ed from the HeLa cells using the RNeasy Plus kit (Qiagen). 
RNA was quanti!ed using an ND-1000 UV-Vis spectrophotometer ("ermo Scienti!c, Wilmington, DE, 
USA), and the integrity of the RNA was assessed with the Agilent 2100 Bioanalyzer (Agilent Technologies 
Inc.) according to the manufacturer’s instructions. All of the RNA samples used in this study exhibited 
a 260/280 ratio above 1.9 and an RNA Integrity Number (RIN) above 9.0.
???????????????????????????????? "e microarray experiment included two biological replicates per 
treatment. All sample-labelling, hybridization, washing, and scanning steps were conducted according to 
the manufacturer’s speci!cations. Briey, Cy3-labelled cRNA was generated from 50 ng input total RNA 
using the One Color Quick Amp Labelling Kit (Agilent Technologies Inc.). For every sample, 600 ng 
cRNA from each labelling reaction (with a speci!c activity above 9.0) was hybridized using the Gene 
Expression Hybridization Kit (Agilent Technologies Inc.) to the Agilent Whole Human Genome Oligo 
Microarray (Agilent Technologies Inc.), which is in a 4 × 44k 60-mer slide format, where each of the 4 
arrays represents approximately 41,000 unique genes and transcripts. A$er hybridization, the slides were 
washed and then scanned with the Agilent G2565BA Microarray Scanner (Agilent Technologies Inc.). 
"e uorescence intensities of the scanned images were extracted and pre-processed using the Agilent 
Feature Extraction So$ware (10.7.3.1).
Gene expression data analysis. Quality control and array normalization were performed in the R 
statistical environment using the Agi4 × 44PreProcess (v 1.18.0) package, which was downloaded from 
the Bioconductor web site. "e normalization and !ltering steps were based on those described in the 
Agi4 × 44PreProcess reference manual. Briey, the Agi4 × 44PreProcess options were set to use the Mean 
Signal and the BG Median Signal as foreground and background signals, respectively. "e data were 
normalized between arrays using the quantile method. Genes with a fold change greater than 1 log2 were 
www.nature.com/scientificreports/
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designated as modulated. All of the above computations were conducted using the R statistical program-
ming environment. Principal-component analysis (PCA) was performed on all genes under investigation 
to determine their expression trends within the dataset. PCA is a useful technique to reduce the dimen-
sionality of large data sets. e expression analysis systematic explorer (EASE) biological theme analysis 
of the regulated genes was conducted online using DAVID.
????????????? ??????? ?? ???? ??????????? ??? ??????????? ?????? A real-time quantitative PCR 
(qRT-PCR) analysis was performed, in triplicate, on the same RNA samples that were used for the 
microarray hybridization to validate the microarray results. One µ g of total RNA was retro-transcribed 
using SuperScript II (Life Technologies, Carlsbad, CA, USA). qRT-PCR was performed using the iQ 
SYBR® Green supermix (Bio-Rad, Hercules, CA, USA,) on the ABI Prism 7000 platform (Applied 
Biosystems) with the following thermal cycling protocol: denaturation for 1 min at 95 °C followed by 40 
cycles of 15 sec at 95 °C and 1 min at 60 °C. e primers are listed in Supplementary Table S3. A relative 
quantitative analysis was performed using the 2−∆∆Ct method.
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The three papers presented in this thesis show that application of 
both gene expression analysis and cell lines to modern toxicology 
may bear several advantages but also some drawbacks. 
The first paper shows the potential of gene expression to explain 
the toxic mechanism of cadmium cancerogenity using HepG2 cell 
line. The second paper utilizes Caco-2 cells to show that gene 
expression can be applied also to study toxic effects of a particular 
material, as nanoparticles. The third paper is a critical evaluation of 
cell lines reproducibility, as this study shows that batches of HeLa 
treated by hypoxia have some differences in the gene profile and 
the genetic analysis shows the presence of high genomic instability.  
The first publication focuses on cadmium and cancer. A suggested 
mechanism of cadmium-induced carcinogenicity involves defects 
in the response DNA damage and the resistance to apoptosis: 
following this idea I focused on the tumour suppressor protein P53 
since its inactivation is a common feature found in human cancers 
and it is a crucial component of the cellular response to DNA 
damage. P53 is primarily involved in defence mechanisms by 
transcriptional activation of genes responsible of growth arrest and 
apoptosis for the elimination of heavily damaged cells. 
The results presented in this thesis demonstrated that in HepG2 
cells exposed to cadmium the P53 was correctly moved and 
accumulated into the nucleus to accomplish its function of 
transcription factor. However, in spite of this correct nuclear 
localization, the signals for the cell cycle arrest were not activated. 
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In this context, P21, a P53 downstream protein, which is an 
important mediator of cell cycle arrest, was upregulated at gene 
level but not at protein level. These results could be explained by a 
post-transcriptional activity by the miRNA, as demonstrated by the 
upregulation of mir-372 in cadmium-treated HepG2 cells, able to 
affect p21 expression and to promote cell proliferation.  
The second study focused on the toxic effect of nanoparticles. In 
this study, gene expression was applied to get insights in the 
mechanism of the cytotoxic effect of gold nanoparticle (AuNP) of 
two different sizes, 5 and 30 nm. The main focus was to compare 
the effect of the two sizes using Caco-2 cells as in vitro model of 
the intestine. 
The smaller AuNPs (5 nm) inhibit Caco-2 cell growth, the gene 
expression analysis showed a broad range of responses induced by 
small size AuNPs which therefore mediate inhibition of Caco-2 
cells growth. 
The results presented indicate that the Caco-2 cells were able to 
recognize 5 nm AuNPs not only as metal but also as potential 
danger signals and stress inducers. This is shown by the 
bioinformatics reconstruction of regulated pathways that indicates 
that Caco-2 cells activate defence responses, even if it was not 
enough to prevent the observed toxic effect. 
The stress resulting from cytotoxic level of smaller AuNPs induced 
down regulation of many genes. The observation of a high number 
of down regulated RNA transcripts in Caco-2 cells exposed to 5 nm 
AuNPs, suggested a possible involvement of miRNA. A 
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bioinformatics approach was applied to predict potential miRNA 
target sequences in mRNAs and a possible involvement of 
miRNAs in this process is suggested. 
The response at the transcriptome level upon exposure to larger 
AuNPs (30nm) level is very weak. This effect can be due to the fact 
that, as already reported in literature, the cellular uptake is higher 
for smaller nanoparticles. In our study we observed the same 
phenomenon, and the higher uptake of smaller AuNPs (5 nm) 
might represent a stronger biologically stimulus. Moreover, it is 
also possible that smaller AuNPs (5nm), with higher surface area to 
volume ratio, have a higher reactivity toward biological molecules 
and are more “disruptive” to the homeostasis of exposed cells as 
compared to larger AuNPs (30 nm). 
The different expression profiles observed in Caco-2 cells exposed 
to the two different sizes of nano-gold particles, gave an additional 
support to previously published findings demonstrating that 
isotropic AuNPs larger than 5 nm seem to be biologically inert 
[82]. 
The third paper focused on the issue about cell line variability 
using different batches of HeLa cells, collected from different 
laboratories. The microarray expression analysis was performed on 
these batches of HeLa cells exposed to hypoxic conditions, chosen 
because the induced hypoxic pathway is well characterized. In 
response to a hypoxic stimulus, each cell line batch activates 
different pathways, although the regulation of genes related to 
hypoxia is conserved. These outcomes strongly suggest that 
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different HeLa batches can give different results in gene 
expression. 
A genetic analysis showed the high level of extensive chromosome 
instability in the HeLa clones obtained from different laboratories. 
Each clone accumulates genomic variability in a time-dependent 
manner, so it possible to speculate that some chromosomal 
rearrangements or point mutations that randomly arose in each 
clone increased survival, leading to a kind of “genetic drift” in 
clonal variants. 
The large differences in gene expression profiles suggest that the 
use of uncharacterized clones may lead to faulty conclusions and to 
irreproducible results in studies of gene function and pathway 
analysis. With respect to genomic content, the use of 
uncharacterized batches of HeLa cells may result in different 
behaviours between clones in response to specific stimuli, such as 
cancer drugs, used in biomedical research. 
In the three papers presented in this thesis I have not only shown 
the reproducibility of microarray by comparison to real time PCR, 
the gold standard for mRNA quantification, but also the capability 
to create possible model for the mechanistic effects on biological 
pathways. Furthermore microRNAs have been integrated in the 
modelling of mechanisms and should be considered important 
potential biomarkers. 
In my thesis I have used different cell lines as in vitro models. They 
have shown that they have many advantages and that can give 
strong support for modern toxicology and can be used to study 
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biological mechanism, although the last publication shows some 
limits, due to the high variability in cell line batches, that have to 
be taken into account. 
I can conclude that microarray and cell lines are powerful tools for 
modern toxicology to study mechanism of toxic compounds. 
Microarray is a mature and solid technology, whereas cell lines 
have been shown to be nice models but have to be used with 
attention. 
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